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” We have not succeeded in answering all our problems. The answers we have found only serve 
to raise a whole set of new questions. In some ways we feel we are as confused as ever, but we 
believe we are confused on a higher level and about more important things.” 
excerpt from “The Workshop Way of Learning” Professor Earl C Kelley, 
Wayne University, USA, 1951.  
Dedication 
This thesis is dedicated to Anita Destinedforgreatness Sackie, R.N, MPH, who 
sadly died on 1st October, 2014 in Monrovia, Liberia of the disease that she was 
fighting in her profession. If everyone had a fraction of your bravery, strength 
and compassion, the world would be a better place. We are forever grateful to 
you and all health care workers in Liberia for saving us all from Ebola.  
ABSTRACT 
Background: A majority of the three million children in Africa that do not survive their 
fifth birthday die from infections that often start as a seemingly uncomplicated febrile 
illness. Primary health care workers frequently encounter febrile children with a negative 
malaria rapid diagnostic test (mRDT), in particular in places like Zanzibar with a 
considerable decline in malaria prevalence. In recent years, accurate and sensitive 
molecular techniques like the polymerase chain reaction (PCR) have revealed increased 
detection of pathogens not only in ill patients but also in asymptomatic subjects. These 
factors underline the importance of re-evaluating the infectious disease aetiology and 
pathogen dynamics in febrile children and to assess whether existing diagnostic tools 
like mRDT and fever management guidelines like the IMCI (Integrated Management for 
childhood illness) remain useful and safe. Methods and Findings: The thesis is based 
on two field studies, both conducted on patients with acute uncomplicated febrile illness 
(by history or axillary temperature) in primary health care facilities April-July 2010 and 
2011 in Zanzibar, Tanzania. In study 1 (paper I), 3890 febrile patients ≥2 months were 
included. Malaria prevalence by mRDT was 3.1%, with the highest prevalence, 6.1% in 
children aged 5-14 years old. Malaria microscopy and PCR were conducted on all 
mRDT positive and a randomly selected 20% of the mRDT negative patients. The 
sensitivities of mRDT versus malaria microscopy and PCR were below 80%, 
respectively. Study 2 (paper II-IV) included 677 febrile children aged 2-59 months of age 
that depending on the clinical picture were subjected to point-of-care tests, PCR 
analyses (on inclusion and day 14), urine culture and radiological analyses. For 
comparison, 167 geographically- and age-matched asymptomatic controls from the 
surrounding communities were recruited for selected PCR analyses. More than one 
pathogen was detected by PCR in 98% of patients and 93% of healthy controls. After 
application of study specific diagnostic criteria using clinical characteristics and 
laboratory results, including a comparison with detection in healthy controls, a cause of 
fever was assigned to 86%. The most common were respiratory syncytial virus (RSV), 
influenza A or B, rhinoviruses, enteroviruses, and S. pyogenes (Group A Streptococcus) 
(paper II and III). C-reactive Protein (CRP) was the only variable significantly associated 
with radiological pneumonia. Antibiotics were prescribed to 74% of patients whereas 
22% had an infection that required antibiotics (paper II). On follow-up after two weeks 
>80% of the infections were cleared, but almost half of the sampled patients had a new 
infection on day 14 (paper IV). Conclusion: The sensitivity of the malaria RDT was 
relatively low. Thus, more sensitive tools than histidine-rich protein 2 (HRP-2) based 
mRDTs are warranted. Most of the uncomplicated febrile illness in children in Zanzibar 
was caused by a viral respiratory tract infection. Comparison of pathogen detection in 
febrile and healthy children was crucial for identifying cause of disease. The accuracy of 
the IMCI guidelines to guide antibiotic prescription was suboptimal with both over- as 
well as underprescription of antibiotics. However, the study did not find any diagnostic 
tool to help in guiding antibiotic prescription although C-reactive Protein might be a 
promising biomarker for future intervention studies. Respiratory infections usually 
cleared within two weeks. However, many children had acquired a new viral infection, 
suggesting that prolonged symptoms often are due to acquisition of new infections 
rather than to persistence.  
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 SAMMANFATTNING PÅ SVENSKA 
Bakgrund: Zanzibar, en ö utanför Tanzanias kust, har de senaste femton åren 
haft en unik minskning av förekomsten av malaria. Tidigare var eldriven 
mikroskopi som gjordes på patientens blod av särskilda laboratorietekniker det 
enda sättet att veta om en patient hade malaria eller inte. De senaste åren har 
man utvecklat snabbtest för malaria som gör att hälsoarbetarna inom femton 
minuter kan ställa malariadiagnos och detta utan att de behöver tillgång till 
elektricitet.   
Trots nedgången i malariaförekonst så dör fortfarande alldeles för många barn 
under fem års ålder med feber. Vi ville därför undersöka om de nya typerna av 
malariasnabbtest är säkra att använda. Dessutom ville vi lite noggrannare studera 
de barn som sökte på vårdcentralen som inte hade malaria genom att använda 
moderna och känsliga metoder (så kallad PCR).  PCR påvisar arvsmassan (DNA 
eller RNA) från bakterier, virus och andra så kallade mikroorganismer. Vi ville 
också jämföra förekomsten av dessa mikroorganismer hos febriga barn med 
barn som mådde helt bra.  
Metoder och resultat: Avhandlingen består av studie 1 (genomförd på ett 
flertal vårdcentraler på Zanzibar och Pemba april-juli 2010) och studie 2 
(genomförd på en stor vårdcentral på Zanzibar april-juli 2011). I studie 1 ingick 
patienter över 2 månaders ålder med feber och alla genomgick ett snabbtest för 
malaria. Av 3890 patienter var tre procent positiva med malariasnabbtestet. 
Dubbelt så hög förekomst av malaria (6%) sågs hos barn som var i åldrarna 5 till 
14 år. För att veta hur väl malariasnabbtesten fungerar så testades en del av 
patienterna även med mer känsliga malariatestmetoder (malaria mikroskopi och 
PCR). Det visade sig att snabbtesten hittade mindre än 80% av de patienter som 
var positiva för malaria genom såväl mikroskopi som PCR.  
I studie 2 ingick 677 barn med feber i åldrarna 2-59 månader. Dessa barn 
provtogs beroende på vilka symptom de hade, exempelvis blodprov, halsprov 
och urinprov. På barn med misstanke om lunginflammation (förekomst av hosta 
och snabb andning) genomfördes en lungröntgen. De känsliga PCR-proverna 
analyserades på pinnprov tagna från näsa/svalg och ändtarm från både patienter 
och 167 välmående barn vilka hittades genom att gå från hus till hus i byarna 
runt omkring vårdcentralen.   
Dessutom togs ett nytt PCR-prov för jämförelse på 25% av patienterna två 
veckor senare.  
Hos 86% av patienterna kunde en trolig feberorsak hittas. De vanligaste var 
luftvägsinfektionsvirus (särskilt RSV och influensavirus) och streptokocker 
(halsfluss). Men vi såg också att förekomsten av potentiellt sjukdomsorsakande 
mikroorganismer hos välmående barn var nästan lika hög som hos patienter 
med feber. Lunginflammation bekräftades med lungröntgen i endast 12% av 
fallen med klinisk misstanke. CRP (så kallad snabbsänka) var signifikant högre 
hos dessa barn med röntgenförändringar än de utan. Endast två patienter hade 
malaria (0,3%) men vi kunde inte hitta några andra tropiska sjukdomar så som 
denguevirus.  Nästan tre fjärdedelar av patienterna fick antibiotika medan endast 
22% hade en bakterieinfektion som behövde antibiotika. I samband med 
uppföljningsprovtagning efter två veckor så hade mer än 80% av infektionerna 
försvunnit, men hos nästan hälften av patienterna hittades en ny infektion dag 
14. Den vanligaste nya infektionen var rhinovirus.  
Slutsats: Känsligheten hos snabbtesten för malaria var relativt låg vilket bland 
annat låg till grund för att snabbtestet byttes ut till ett annat på Zanzibar efter 
studie 1. Till skillnad från vad man tidigare trott så hade de flesta barn med feber 
en virusinfektion som försvann inom två veckor, men många fick en ny 
virusinfektion under samma tid. Det verkar således som om att barn konstant 
utsätts för nya infektioner men är bra på att snabbt läka dem. Förekomsten av 
vissa bakterier och virus var i många fall lika vanlig hos patienter som välmående 
barn. När vi jämförde tillgängliga riktlinjer för antibiotikabehandling såg vi att 
både över och underbehandling var vanligt.
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INTRODUCTION 
Global child mortality has decreased substantially over the past two 
decades, but still each year almost six million children succumb to easily 
preventable or treatable diseases1. Most of them die in resource limited 
settings and almost half in sub-Saharan Africa (SSA)2. However, they 
often initially present to primary health care 3 or a drug shop4 with a 
seemingly non-severe febrile illness.  
Despite the fact that infectious diseases like malaria5, rotavirus6, and 
pneumococcal infections7 are considered the major killers of preschool 
children, in-depth studies on aetiologies of uncomplicated childhood 
febrile illness in Africa are scarce8.  Epidemiological fever studies often 
focus on one specific pathogen, diagnosis or disease, or on include 
severely ill children9. Thus, it may be difficult to grasp the cause and 
proper management of febrile illness10 11, in contrast to pneumonia and 
diarrhoea which have been more thoroughly studied12-16. Moreover, most 
fever studies are hospital-based or investigate selected patient groups, 
some use out-dated techniques, and others do not include healthy 
controls for comparison 9 17 18.  
Zanzibar is an island off the Tanzanian coast that in the recent decades 
has had an extraordinary success in controlling malaria19 and is now trying 
to reach the goal of elimination. This has been achieved through 
coordinated interventions on vector control, diagnosis and treatment. 
The island was also one of the first to introduce point-of-care Rapid 
Diagnostic Tests (RDT) for the diagnosis of malaria. The malaria rapid 
diagnostic tests (mRDT) were evaluated after introduction and regarded 
safe and cost-effective20, but this was in 2005 when every third patient 
had malaria, whereas in 2010 official figures indicated a tenth of that. 
Hence it is important to re-evaluate the infectious aetiology and pathogen 
dynamics in febrile children as well as to assess whether existing 
diagnostic tools like mRDTs and management guidelines (like the 
Integrated Management of Childhood Illness- IMCI) including antibiotic 
treatment remain useful and safe21. 
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The thesis highlights aspects of diagnosis, management and treatment of 
uncomplicated febrile illness in this low malaria endemic setting. It 
reflects upon which considerations to be made when attributing cause of 
fever in a preschool child, looking at the patient and the pathogens, risk 
factors, levels of severity, inclusion criteria and study definitions and also 
the pitfalls of interpretation as well as clinical management. The project is 
divided into two studies study 1 (paper I) and study 2 (paper II, III and IV).   
The aim of study 1 was to evaluate whether the mRDT, was still an 
effective tool to identify and rule out P. falciparum infection on primary 
health care level after the recent decrease in malaria prevalence. Would 
prescribers continue to adhere to the mRDT results when over 95% of 
the tests were negative and alternative diagnostic tools for fever 
management were scarce? The aim of study 2 was in addition to decipher 
aetiologies of non-severe febrile episodes in children by applying sensitive 
real-time polymerase chain reaction (PCR) techniques also to 
demonstrate whether the comparison of pathogen load and detection in 
febrile children versus healthy controls aid in deciding which pathogen 
that is causing the fever. This final diagnosis was compared with the 
corresponding IMCI classification and treatment.  
 
Febrile illness has a substantial impact on a low-
income society   
Fever is one of the most common reasons for parents seeking medical 
advice for their children in low-income countries3 22. The community fever 
prevalence in children, defined as ‘history of fever in the preceding two 
weeks’, is estimated to be around between 10-28% in sub-Saharan 
Africa23-26 (Shakely et al, unpublished data*), and significantly higher 
among poorer than wealthier children25 26. Also, the younger the patient, 
the higher is the fever incidence27.  
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Febrile illness has a substantial impact on the lives of poor people living 
in malaria endemic countries, and it is also the poorest of the society who 
have the highest risk of contracting a fever28. Still, this is the group of 
children who has the least access to health care services29. The poorer the 
patient and the more severe the febrile illness, the higher the amount that 
the caretaker has to pay from out-of-pocket30 31. Many febrile illness 
prevention and treatment strategies, like the World Health Organization 
(WHO) extended programme of immunization (EPI)32, malaria control 
and elimination programs33 and integrated community management 
programs34 are cost-effective. However, on a policy maker level, the issue of 
affordability is often just as important. A good example is the management 
of Acute Rheumatic Fever, (ARF) especially in low- and middle-income 
countries (LMICs). Primary and secondary prophylactic interventions 
against group A streptococci (GAS) are regarded as highly cost-effective 
for the prevention of ARF but the gain is reached after a longer period of 
time and the public investments before that are quite high and sometimes 
not affordable35.   
Conclusion: Defining the causes of fever in the poorest young children 
is particularly important since they have the highest disease burden.  
*Unpublished data from cross-sectional studies. Reports of fever in the last 14 days were relatively 
similar in 2003, 2006, 2007, and 2009 (13%, 12%, 9%, and 15%, respectively).  
 
Fever definition in low-income malaria endemic 
settings  
Fever is defined in the PubMed Mesh headlines as “An abnormal 
elevation of body temperature, usually as a result of a pathologic 
process”. Most research on acute febrile illness applies a maximum 
duration of fever of less than 7 days for included patients. Patients that 
have had fever for over a week are quite rare in comparison and usually 
fall in to another category like Fever of unknown origin (FUO) that more 
often have other aetiologies than infections that explain their condition 
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like connective tissue disorders, systemic vasculitides and malignancies36. 
Moreover, a distinct study-specific cut-off in temperature that defines a 
fever is often applied. Examples are case definition of influenza-like 
illness (ILI) and typhoid fever which both include a measured 
temperature of >38°C37 38. However, enrolling only those patients that 
are febrile on presentation and excluding those with merely a history of 
fever could decrease the sensitivity to diagnose some infections. The 
most evident example is malaria that often manifests with an intermittent 
fever pattern39. Also a thermometer is often not available in the 
peripheral health centres in SSA. Thus management guideline that 
includes only a measured fever might be less useful in resource limited 
settings40 41.  
Consequently, fever studies and clinical algorithms in malaria endemic 
settings often use a cut-off of 37.5°C in axillary temperature and/or 
history of fever in the preceding days as a marker for febrile illness. This 
approach is supported by the fairly high sensitivity of caretakers’ report 
of fever still keeping in mind that fever prevalence may be 
overestimated24 42-46.  Thus, parents who deny the presence of fever are 
often accurate but the opposite must be confirmed. History of fever as a 
part of febrile illness definition has been an important indicator when 
performing studies in settings with high malaria endemicity.  However, 
with decreasing malaria prevalence, this notion might be questioned 47, 
especially in older children48.  Yet, multiple studies show that no 
universally applicable criteria exist that differentiate malaria diagnosis 
from other febrile illnesses in malaria endemic areas. Especially in low 
endemic areas, malaria microscopy or other parasitological confirmation 
is required for an accurate diagnosis48 49.  
Conclusion: The definition of fever in malaria endemic low-income 
countries has to incorporate history of fever to be useful but with 
decreasing malaria prevalence this could be questioned.   
  
  7 
Malaria epidemiology and risk in sub-Saharan 
Africa 
The most important cause of febrile illness historically continuing to this 
date both considering the impact on morbidity and mortality is the 
mosquito-borne disease malaria50.  The most common and dangerous 
type of malaria is caused by the single-celled, eukaryote protozoan 
parasite Plasmodium falciparum. There are 4 other types of malaria species; 
Plasmodium malariae, Plasmodium ovale, Plasmodium vivax, and lastly the most 
recently discovered Plasmodium knowlesi. The first three are all endemic in 
Africa. P. knowlesi and P. vivax use the duffy blood group antigen to enter 
the erythrocyte. In sub-Saharan Africa, the proportion of persons that are 
so called duffy negative is high51. These persons have previously been 
regarded resistant to these two latter types of malaria parasites52. Yet, 
recently this notion has been questioned, and P. vivax may be more 
common in Africa than previously thought53 54 but instead illicit low grade 
parasitaemias in duffy negative persons that previously might have gone 
under the radar55.  
Global malaria prevalence has declined in the recent decades and also in 
Africa, in some places more, less in others19 56.  Still, in some areas half of 
the febrile patients are positive for malaria57-59, but even in these 
circumstances, a great proportion is not explained by only malaria23. 
Children and pregnant women are the most vulnerable groups, but 
everyone affected has a relatively high risk of severe disease or even 
death, especially for non-immune persons like travellers and migrants 
moving from a non-endemic to a malaria endemic area. The risk is 
increased with time from fever onset to diagnosis and treatment, with 
children typically having a shorter time-span before they reach a severe 
disease state. The most common and typical symptom of malaria is a 
fever, whereas severe malaria in children is characterized by signs of 
shock, hypoglycaemia, severe acidosis and anaemia60.  
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Parasitological confirmation of malaria 
The current gold standard for malaria diagnosis is a standardized 
microscopy reading of a thick blood smear to define parasitaemia count 
and a thin smear for species identification61. In malaria research studies, 
two microscopists are used and if there is discordance between the two 
independent readings, a third and decisive reading will be made. Other 
traditional laboratory methods like parasite culture might be used for 
determination of resistance to antimalarial medicines62. Immunoassays 
like Enzyme Linked Immunosorbent Assays (ELISA) tests could be used 
for mass screening of malaria antigens and antibodies/serology before 
blood transfusion63 or as a tool in epidemiological studies on for instance 
elimination strategies19 64.  In the recent decades, two new techniques 
have emerged that have had an impact on malaria epidemiology and 
clinical management, malaria rapid diagnostic tests and nucleic acid amplification 
tests (NAAT)61 like PCR.  
The disadvantages of gold standard malaria microscopy are that it is 
labour intensive, time consuming, and electricity dependent. The quality 
of the result also relies on the skills of the microscopist. In routine health 
care this is often therefore unattainable. Hence, on the first level of health 
care, malaria diagnosis has historically been made through clinical 
suspicion without a malaria test. The WHO also used to recommend 
presumptive antimalarial treatment to all febrile children below five years 
of age. Malaria RDTs were developed with the purpose to diagnose 
malaria in peripheral facilities where access to microscopy is unreliable. 
Initially the tests were relatively expensive and therefore integration of 
the tests in fever algorithms like the IMCI was regarded not feasible65. 
But gradually the prices were lowered and, consequently in 2010, the 
WHO changed its global policy to recommend only laboratory 
parasitological confirmation (by microscopy or RDT) before treatment66. 
This decision was preceded by a debate where those advocating that the 
mRDT should replace or extend the malaria diagnostic services and be 
combined with a test-based treatment had the opinion that the previous 
reasons for a presumptive malaria treatment in Africa were not valid 
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anymore like high malaria prevalence in febrile children and lack of an 
effective POC malaria diagnostics, when malaria rapid diagnostic tests 
were available, accurate67 68 and safe69. Furthermore, with the introduction 
of the new and potent antimalarials artemisinin-based combination therapy 
(ACT), a restricted use only to those patients with parasitologically 
confirmed malaria infection was regarded necessary. This would avoid 
development of artemisinin resistance which had been shown in other 
malaria endemic areas70 as well as decreasing late diagnosis of malaria 
negative infections. Researchers arguing for a continued presumptive 
treatment thought that there was still not enough evidence to support 
that mRDTs were safe and that ACT prescription could be restricted to 
only those that were test positive71.  
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Figure 1. Author of the thesis holding one of the two P. falciparum positive malaria Rapid 
Diagnostic Tests in study 2. Combination of detection of HRP-2 as well as Pan-specific 
pLDH.  (SD Bioline ®). Photo: Kristina Elfving.  
mRDTs are lateral flow immunochromatographic test platforms 
containing monoclonal or polyclonal antibodies to detect malaria specific 
antigens in blood via a colorimetric transformation on a nitrocellulose 
strip (see Figure 1). The technique is similar to point-of-care HIV tests 
and throat swabs for GAS that give a qualitative test result, i.e. positive or 
negative with a control line. Reading is easy and could be analysed quickly 
in 10-20 minutes. Most mRDTs have a detection limit of 200 
parasites/uL. There are two basic types of malaria RDTs; histidine-rich 
protein 2 (HRP-2) based tests that detect only P. falciparum malaria and 
aldolase or Plasmodium lactate dehydrogenase (pLDH) tests which are both so 
called pan-specific, i.e. present in all 5 types of malaria species. Thereby 
distinction between the more fatal falciparum malaria and other malaria 
species can be made. Figure 1 shows a positive malaria test that combines 
HRP-2 and pLDH detection for malaria identification. Recently, species-
specific mRDTs have been developed also for P. vivax 72.  
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Molecular parasitological confirmation, which is based on more sensitive 
PCR-techniques, both quantitative and endpoint PCRs, have revealed the 
presence of low parasitaemias below the threshold of mRDTs and blood 
microscopy19 73 74. NAAT techniques can also help to differ between 
malaria recrudescence and reinfection75 as well as to detect molecular 
markers that are associated with antimalarial drug resistance. This 
complements the traditional in vivo and in vitro techniques for measuring 
malaria parasite resistance76 61. Some argue against conventional malaria 
microscopy. They are in favour of highly sensitive PCR as gold standard 
for diagnosing malaria in research studies. The argument for is the 
increased relative importance of patients with parasitaemias below the 
detection limit of RDT/microscopy as infectious reservoirs, especially in 
low transmission settings with previous high endemicity and thus high 
herd immunity in the population73 74.  
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Figure 2. Map of Zanzibar. Source: Wikipedia/Oona Räisänen  
  13 
Zanzibar, a model of success  
Zanzibar is comprised of two islands 50 nautical miles from mainland 
Tanzania (Figure 2) with around 1.3 million inhabitants. This semi-
autonomous region has in the last twenty years shown a remarkable 
success in the control of malaria with a dramatic reduction of Plasmodium 
falciparum prevalence among febrile patients presenting at primary health 
care facilities19 77. This is the result of coordinated, integrated, wide-scale 
malaria control interventions, which started in 2003 with the deployment 
of artemisinin-based combination therapy (ACT) to all public health facilities.  
ACT was followed by vector control measures, initially with the universal 
distribution of long-lasting insecticide treated nets (LLIN) to all pregnant 
women and children <5 years of age in 2005 and in 2006, universal 
coverage of indoor residual spraying (IRS) of the houses before the rain 
season was launched. A cornerstone in this comprehensive approach has 
been parasitological confirmation of the infection instead of presumptive 
malaria treatment of all febrile patients. Therefore, already in 2006, 
malaria RDTs were introduced in all public primary health care facilities 
(so called PHCUs) that were beyond the reach for microscopy and 
previously had either to refer the febrile patient for malaria microscopy or 
give presumptive malaria treatment. The first test was a HRP-2 based 
test19 (Paracheck ®) which in 2011 was replaced by a combination of 
analysis of pLDH together with HRP-2 integrated in the same test device 
(SD Bioline Pf/Pan ®, see also Figure 1). 
Previously, in Zanzibar, malaria transmission has been stable with 
seasonal peaks related to the annual rainfall that usually occurs during 
March to May and October to December. Anopheles gambiae complex has 
been considered the main vector, and P. falciparum the predominant 
malaria species. mRDTs have the potential to improve malaria diagnosis 
on the first level of care.  Concerns have been raised regarding test 
performance with the risk of high false positivity rates in high endemic 
settings78 and false negative rates in low malaria endemic settings like 
Zanzibar. Hence, sensitivity would be considered the main problem since 
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low parasitaemias below the threshold of mRDTs might be more 
clinically relevant79.  
Another issue is the lack of health worker adherence to malaria test 
results, both positive and negative results, i.e. under and overprescription 
of antimalarials80-82. In 2006 in Zanzibar, HRP-2 based RDT-aided fever 
diagnosis in primary health care facilities was shown to be efficient for P. 
Falciparum detection, with a sensitivity of 92% and a specificity of 88% 
when compared with blood smear microscopy. Also, it resulted in 
improved adequate treatment and health outcome20. However, the study 
was conducted during a time when P. falciparum malaria prevalence among 
feverish primary health care patients was around 30-40%83. Now recent 
research and official figures show that around 2% of patients that present 
to health care facilities with fever or history of fever have P. Falciparum 
infection and the incidence of symptomatic malaria cases is less than 3 
per 1000 inhabitants. The community prevalence of malaria is around 
0.1% using mRDT or microscopy whereas the corresponding figure for 
malaria PCR is 1,8%. Still of note, in 2002, community parasite 
prevalence by PCR was 25%19.  
Conclusion: There is a need to study the usefulness of mRDT when 
malaria prevalence has decreased and new molecular techniques have 
added to the complexity of malaria diagnosis.   
 
Non-malarial febrile illness  
With the decrease in malaria prevalence in some areas in Africa 19 there 
has been an increasing interest in those febrile patients that do not have 
malaria, especially considering the observed higher mortality rate in 
febrile children with a negative malaria test in comparison with those who 
are malaria positive84. Non-malarial febrile illness (NMFI) was an 
abbreviation introduced first in peer reviewed literature by Uzochukwu et 
al in 200985. It has since then often been used as a term for fever episodes 
in a malaria endemic country that is not caused by malaria, or as defined 
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by Muro et al; “the situation of a patient with suspected malaria and a 
negative parasitological test”86. Research on NMFI has often been 
focused on diagnosing invasive bacterial infections and not so much on 
viral infections or uncomplicated fevers. The dichotomous variable in the 
NMFI definition; fever with or without malaria has been questioned to 
be too binary, since co-infections with malaria and other pathogens, like 
non-typhoidal salmonellosis are quite common10 87.  
To exemplify this, a study from Tanzania on children 6 months to 15 
years of age with different levels of disease severity, conducted in two 
outpatient departments; one hyper endemic (46% of patients had malaria) 
and one with lower endemicity, showed bacteraemia in around 3% of 
patients. Interestingly, bacteraemia prevalence was similar in the NMFI 
patients as in the malaria patients and overtreatment with both 
antimalarials as well as antibiotics was common88. In the hyperendemic 
site overtreatment with antimalarials to malaria negative patients was 
associated with more than one IMCI danger sign, prolonged fever and 
high fever89. This may not be so surprising considering the notion that 
most patients do have malaria and the perceived high risk of missing a 
severe malaria case might play an important role.  
Yet, over diagnosis of malaria in severely ill children could be dangerous 
since it could mislead the clinician from diagnosing the actual cause of 
the severe disease90 Thus, many have advocated simultaneous 
administration of intravenous antibiotics in these children91. But how 
should the clinician manage this issue in the less sick children? The 
problem of symptom overlap in febrile children between malaria and 
pneumonia, like vomiting and rapid breathing has been well described92 93 
but, in addition, these symptoms could also be cardinal symptoms for 
acidosis, pain and congenital heart and lung disease.  
Conclusion: There is a need to study the causes and the management of 
non-malarial febrile illness especially in areas like Zanzibar that have had 
a decline in malaria prevalence.    
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Attributing cause of fever using clinical case 
definitions  
Accurate clinical case definitions are useful for research and public health 
disease surveillance, not only to diagnose infections causing febrile 
disease in a patient but also to serve as a tool in epidemiologic 
surveillance like outbreak alerts and evaluation of disease control 
interventions.  
The ideal case definition needs to be concise, uncomplicated, useable, and 
based on a combination of signs and symptoms that uniquely identify the 
disease of interest94. However, case definitions using merely clinical signs 
and symptoms are seldom both sensitive and specific. Instead, one has to 
make a trade-off depending on whether it is more important to identify 
or to rule out the infection48, both when studying the epidemiology and 
seasonal patterns of a pathogen and when managing the patient. For 
example, in a measles outbreak, finding the patients who are transmitting 
the disease is more important and false positive cases might not have 
such great consequences as false negative cases. Conversely, a high rate of 
false positive tuberculosis diagnoses could be more troublesome due to 
the long and often complicated treatment.    
Hence, clinical case definitions are often not optimal as the only tool. 
This is especially true in infants and when unspecific disease 
manifestations are typical of a certain disease or if there is significant 
symptom overlap between common diagnoses like in arbo- (arthropod-
borne) viral infections95 96, typhoid disease/enteric fever97 98, pneumonia92 
93 influenza27 18 and malaria99. For dengue virus this has become even 
more evident in the recent decade with newly discovered or re-emerging 
diseases like chikungunya and zika virus that all have overlapping 
symptoms of fever, rashes and arthralgia/myalgia. Initiatives have been 
made to increase the utility of case definitions by adjusting the criteria in 
fever epidemiology studies. Here are two examples; in an epidemiological 
situation where all three arboviruses zika, dengue and chikungunya co-
exist, the absence of fever in a patient made the zika diagnosis more 
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likely100. Adding the measured fever to the WHO pneumonia definition 
increased specificity to diagnose radiological pneumonia from 16% to 
50%101.  
Despite the above mentioned difficulties, a large study on febrile disease 
in Tanzania102 showed that it was actually possible to decipher some 
clinical signs or symptoms that point towards a specific aetiology of fever. 
They found that the strongest predictor for ruling in malaria was a high 
body temperature of >40°C, for typhoid; abdominal tenderness, for 
radiological pneumonia; abnormal chest auscultation and for any type of 
bacterial disease; chest indrawing. The strongest predictor to rule out 
urinary tract infection (UTI) was patient age ≥3 years.  
Thus, planning of clear entry points and structured case record forms in a 
research study on febrile illness aetiology are vital and could include 
presence of concomitant symptoms or signs like convulsions, watery or bloody 
diarrhoea, clinical pneumonia or rapid breathing. One example is the 
different clinical case definitions of influenza.  
Influenza-like-illness (ILI) was initially defined as a fever with a cough 
and/or sore throat27. Severity of illness is part of another similar influenza 
case definition, SARI (Severe Acute Respiratory Tract Infection)103 104. 
Yet, Jones et al showed that influenza detection was higher especially in 
older children if instead of SARI, the syndrome “acute febrile illness” was 
used which in contrast to both ILI and SARI does not contain any 
respiratory component103. In line with this, in a cross-sectional influenza 
study from Senegal on febrile persons found in their home, between 7-
18% of febrile participants were positive for influenza of whom only half 
actually qualified for the ILI syndrome27. This was confirmed by studies 
from Kenya and Singapore where the ILI syndrome was suboptimal to 
diagnose laboratory confirmed influenza whereas the syndrome “cough + 
fever” without the criterion sore throat showed a good sensitivity and 
specificity37 105.  
Consequently, in 2011, in the aftermath of the 2009 H1N1 pandemic, 
WHO made revisions of both the ILI and SARI syndromes with the goal 
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to increase sensitivity without compromising specificity to detect 
influenza infection. The major change was to omit the sore throat 
criterion from the definition and subsequently influenza-like-illness was 
defined:  “An acute respiratory illness with a measured temperature of ≥ 
38 °C and cough, with onset within the past 10 days”94.  
Similar to influenza disease, there is a need for a consensus case 
definition for respiratory syncytial virus (RSV) studies in low-income 
countries. Rha, Dahl et al showed that the SARI syndrome only detected 
51% of RSV cases <3 months of age and by removing the fever criterion 
from the SARI and use that as a case definition for RSV, the detection 
increased to 98%106. The authors also pointed out that fever was more 
common in children >12 months of age in RSV positive versus RSV 
negative children with SARI. Thus, the study highlights the importance of 
including age-specific criteria in a clinical case definition.  
Case definitions of diarrhoeal disease are usually better defined and thus 
more easily comparable between research studies and report systems. 
WHO regards diarrhoeal disease as ”passage of three or more loose or 
liquid stools per day (or more frequent passage than is normal for the 
individual”. However, most studies on diarrhoeal aetiology use the more 
precise definition of ≥3 loose stools within the previous 24 hours and 
also include a maximum duration of symptoms to 7 days107 12 to define an 
acute diarrhoeal episode. The quality of the diarrhoea is evaluated to 
further characterize the population, i.e. watery or bloody diarrhoea which 
indicates a mucosal inflammation, and dehydration status which indicates 
disease severity108. Hereby, the case definitions are also useful in an acute 
diarrhoeal outbreak situation of for example shigellosis or cholera. 
Narrowing or broadening the criteria for clinical case definitions must be 
done with caution, especially if used in clinical practice. The decision of a 
primary health care worker to treat an illness based on only caretaker 
history and clinical signs has been shown to save lives in low resource 
settings both for malaria109 and pneumonia110, two major child killers in 
Africa.  
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Conclusion: Previous reports on causes of fever have not always been 
comparable due to differences in the studied parameters like type of 
pathogens, different levels of severity and age categories. Hence, it is vital 
to standardize case definitions and inclusion criteria both in public health 
surveillance and as well as aetiology studies, to make the results 
reproducible and translatable to other settings.  
 
Clinical algorithms for febrile children low 
resource settings and change in epidemiology 
With a decline in malaria incidence, the health worker increasingly 
encounters a febrile patient with a negative mRDT. The fact that places 
like Zanzibar despite the lower malaria prevalence continue to have a 
high child mortality rate underlines the importance of providing evidence 
on other aetiologies of fever than malaria in children. In this new 
epidemiological context it is important to re-evaluate the aetiology of 
acute uncomplicated childhood fever and also to assess whether existing 
diagnostic guidelines and management tools remain useful and safe21, 
especially considering identification of infections that would require 
antibiotics.   
The Integrated Management of Childhood Illness (IMCI) guidelines111 112 were 
developed by the WHO and the UNICEF to improve primary health 
care workers’ clinical management of preschool children focusing on the 
main conditions contributing to under-five morbidity and mortality. The 
goal was to move away from vertically oriented health programmes and 
to integrate knowledge into one holistic approach, which would be 
patient-centred rather than disease-oriented. IMCI is comprised of simple 
stepwise algorithms based on specific entry symptoms and clinical signs 
that are found on clinical assessment like fever, ear pain, diarrhoea and 
respiratory rate. These parameters correspond to a classification and a 
recommended treatment and management including referral for severe 
patients. In addition, it has an integrated preventive focus on vaccines, 
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nutrition and anaemia (including antihelmintics) as well as 
recommendations for follow-up depending on disease classification at 
initial visit. Moreover, the IMCI has since its start two decades ago a 
comprehensive family/community approach and focus on improvement 
of case management skills of health care workers and strengthening of 
the health system where they work21 113 114. The IMCI was also used as the 
foundation when developing the Community Case Management system 
(iCCM) used by community health workers (CHW) to manage common 
childhood illnesses including the fever syndrome in the community115.  
The emergency assessment and treatment (ETAT)- strategy was 
developed to be used complimentary to the IMCI or iCCM for children 
needing prompt emergency care and referral management116. Despite the 
fact that these three guidelines are designed to be used in the same 
settings, there is sometimes confusion as to which guideline to use and 
where and how to implement or scale it up117. Subsequently, results from 
studies evaluating one of the guidelines can not immediately be 
generalised to all three. For example, CHWs are able to manage malaria 
and pneumonia effectively and safe in their community through the 
iCCM strategy118 and mRDTs probably reduce the overtreatment with 
antimalarials but might increase antibiotic use instead119. However, this 
does not necessarily mean that the results are translatable to the health 
facility based IMCI or ETAT, although the guidelines seem similar in 
their structure.   
Despite the fact that the IMCI is the guideline recommended for children 
who reside in LMICs, the majority of studies have up to now focused 
mainly on IMCI implementation, supervision120, and health worker 
adherence to the guideline121 122. After the launch of the guidelines in the 
end of the 1990s, there were some studies from India that reported 
clinical utility of the integrated approach of the guideline. They also 
showed superiority of the IMCI in comparison with the vertical approach 
guidelines, in particular when the caretaker had multiple complaints123-125. 
But after that, only a few guidelines focused on the usefulness and safety 
of the clinical management recommendations or suggestions for further 
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guideline adaptation for conditions like pharyngitis and severe 
pneumonia126-130. A recent Cochrane report129 shows that when IMCI 
management does reach the child, it is cost-effective131 and increases 
quality of care128 129 132, e.g. it improves pneumonia case management110, 
rational use of antimicrobials133 134 and antimalarials. However, IMCI was 
developed when global child mortality was almost double of what it is 
today. Thereafter, there have been changes in infectious disease 
epidemiology of childhood febrile illness following e.g. introduction of 
new diagnostics like malaria RDT and preventive measures like up-scaled 
malaria interventions and immunizations against pathogens like 
rotavirus135 and pneumococci136. Hence, concerns have been raised that 
the IMCI technical base is old113, not evidence based21 and most 
importantly seldom actually adjusted for local epidemiology137.  
Conclusion: It is necessary to re-evaluate IMCI in new epidemiological 
and diagnostic contexts, especially when malaria prevalence is declining 
and new rapid tests are being implemented121. This is particularly true in 
Zanzibar, which already in 2009 was one of the first areas to include the 
mRDT in a locally adapted IMCI version of the IMCI guidelines111 138.  
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Pneumonia diagnosis in resource limited 
settings  
Pneumonia is according to global epidemiology studies the largest killer 
in children. The annual global death toll is more than 700 000 children 
under 5 years of age, half of which are thought to occur in Africa, 
although estimates are relatively uncertain7. Paediatric pneumonias 
manifest in a majority of the cases with a fever139. However, there is no 
existing gold standard for pneumonia diagnosis neither in high-income140 
141 nor in low- and middle-income settings. Hence, previous pneumonia-
focused literature, guidelines or research are rather heterogenic, especially 
for preschool children140 142 143.  
IMCI defines a pneumonia that requires antibiotics as the ‘presence of 
cough and/or difficult breathing in a child with rapid breathing’ (age-
dependent cut-offs to define increased respiratory rate). The child should 
be evaluated for tachypnoea when it is afebrile, calm and not hungry, 
which sometimes might be difficult to attain especially in a low-income 
setting144. The pneumonia algorithm within the IMCI guideline is similar 
to the previous lower respiratory tract infections (LRTI) guideline 
launched by the WHO. The development of this pneumonia strategy in 
the 1980s was based on studies performed on children with pneumonia 
diagnosis in the US145, which showed that the presence of fast breathing 
had a good sensitivity to rule in pneumonia.  
The results were confirmed in studies in low-income countries including 
sub-Saharan Africa139 146 and consequently, tachypnoea became central in 
the pneumonia diagnosis strategy. But already these studies, which 
formed the basis for the LRTI strategy identified the same problems that 
afterwards have been shown in follow-up studies such as inability of 
health care workers to identify danger signs and the importance of 
training and supervision. Also, recently after the introduction of 
pneumococcal vaccine studies conducted in paediatric emergency rooms 
in the US, showed on the contrary a low sensitivity (34,3%) of the WHO 
pneumonia cut-offs to rule in pneumonia147.  
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Due to the lack of a gold standard, even in high-income settings, the 
decision of a qualified physician to treat the child for a bacterial 
pneumonia is often used to define a pneumonia diagnosis. This lack of a 
clear-cut objective endpoint for pneumonia diagnosis often impedes 
scientific and programmatic evaluation of pneumonia and LRTI 
management strategies.   
The closest to a gold standard is a pneumonia identified on a chest X-ray 
(CXR). CXR is recommended by the WHO to define the endpoint 
radiologically confirmed pneumonia in most pneumococcal vaccine 
effectiveness studies and there is also a systematic guideline on 
interpretation148. The CXR interpretation is divided into four groups 
“endpoint consolidation” which should represent a radiologically verified 
pneumonia, “other infiltrate” which should not be regarded as 
pneumonia and “normal” and “uninterpretable”. There are also 
standardized instructions on how to digitalize analogue pictures for 
interpretation and reading to be performed elsewhere than on-site. 
Similar to studies on malaria microscopy, reading should be performed by 
two radiologists and if there is disagreement a third and decisive reading 
should be initiated.  
Conclusion: Radiologically verified pneumonia is still the best at hand 
gold standard instrument in pneumonia research.   
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Antibiotic resistance  
Many children all over the world do not have access to a correct 
antibiotic treatment when they need it due to lack of money, a high cost 
of the most efficacious antibiotics, inappropriate use, and counterfeit 
drugs149-152. Another change in infectious disease epidemiology in the 
recent decades are the increasing rates of antimicrobial resistance (AMR), 
which is not only affecting high-income countries but also SSA.  WHO 
has defined antibiotic resistance as a major threat to global health.  
AMR should be tackled on the following fronts: Public and health worker 
awareness, optimized use of antibiotics in agriculture and human health, 
strengthened research and surveillance, investment in human capital, 
increased infection control (sanitation, hygiene and prevention), increased 
investment in new therapeutic approaches (including antibiotics and 
vaccines), diagnostics tools and other interventions150.  
It is suggested that the problem of antibiotic resistance might even be 
higher in LMICs than high-income settings152-154. Despite this, few efforts 
have been put in place to tackle the problem of resistance in low-income 
settings also considering that the lack of expertise is probably even higher 
there. Naturally, the global IMCI strategy could be suitable as a focal 
point in the work against AMR. One particularly important area of 
interest within the IMCI would be the pneumonia/LRTI algorithm due 
to the high rate of overprescription of antibiotics. Furthermore, there is a 
worry that following the decline in malaria prevalence, febrile children 
who previously would have received presumptive malaria treatment 
through clinical recommendations would now receive antibiotics for a 
suspected pneumonia instead155. This is true in particular when 
considering the great symptom overlap between malaria and pneumonia 
described above.   
Conclusion: Changes in causes of febrile disease in sub-Saharan Africa, 
decline of malaria prevalence in some areas and increased antibiotic 
resistance call for re-evaluation of the antibiotic recommendations in 
guidelines like the IMCI.   
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Invasive bacterial infections in febrile paediatric 
outpatients in Africa 
It is difficult to draw any conclusion on the burden of invasive disease in 
children with uncomplicated febrile severe illness. Fever studies in sub-
Saharan Africa often include a mixture of patients with different levels of 
severity, have a wide age span (from neonates to old adults), and include 
children with measured fever only. The risk of contamination of blood 
cultures with skin bacteria from the patients makes the interpretation 
more difficult156. Typically, bacteraemia frequency in these heterogenic 
patient groups is less than 10% and the most common pathogens isolated 
are S. pneumoniae, S. typhii, non-typhoidal salmonellosis (NTS), E.coli, and 
S. aureus157-163.  
The few studies from SSA report a bacteraemia prevalence of around 1-
1.5% in children with non-severe illness68 164 165. The most common 
pathogens detected are e.g. pneumococci and invasive salmonellosis, 
similar to the community-acquired bacteraemias in more severely ill 
children68 164. Yet, most of the studies have been performed in a setting 
before the introduction of pneumococcal vaccines in the routine 
vaccination programme, the EPI. African children are to an increasing 
extent receiving pneumococcal vaccination (PCV). In addition to an 
increase of invasive non-PCV pneumococcal types after the PCV 
introduction, (so called serotype replacement) which has been reported in 
most places that introduced the vaccine166, one could also predict that 
typhoid and other gram negative bacteria might increase their relative part 
of invasive disease, in preschool children.  
Invasive NTS are common in infants living in SSA and have a 
documented association with malaria infections167 168, whereas most 
previous studies report a significantly higher typhoid incidence among 
older children. Still, S. typhii is a well-documented bacteraemia pathogen 
also in children under 5 years of age68 98 157 161 and in areas with decreasing 
malaria incidence, typhoid takes a greater part of the invasive 
salmonellosis87. This possible rise of gram-negative bacteria taking a 
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greater toll of the IBI as well as a possible increase in AMR could have 
implications on guidelines for empiric antibiotic use in children with 
suspected severe febrile illness.  
Conclusion: One percent of preschool children with febrile disease 
without danger signs have bacteraemia of which most are S. pneumoniae, S. 
typhii, NTS, E. coli, and S. aureus. 
  
Attributing cause of fever using molecular 
techniques  
Molecular methods developed in the recent decades, have led to an 
improved understanding of infectious disease epidemiology14 15. 
Conventional methods used before molecular techniques were put into 
practice like serology, bacterial and viral culture or other types of antigen 
detection are often time-consuming with mediocre levels of sensitivity 
and specificity169-173. The most common type of molecular technique or 
nucleic acid amplification technique (NAAT) is the Polymerase Chain 
Reaction (PCR) which can detect genetic material from all kinds of species. 
It has revolutionised the understanding of in particular infectious diseases 
with its increased sensitivity to detect pathogens from a sample174 175.  
The pathogen concentration can be measured by the real-time PCR 
technique which gives the Ct (threshold cycle) value, a parameter that is 
negatively proportional to the logarithm of the target concentration. The 
real-time PCR also allows for simultaneous detection of multiple agents. 
Moreover, sensitive multi-targeting techniques have revealed that 
asymptomatic individuals frequently carry pathogens, not seldom to the 
same extent as patients, with both conventional176 177 15, and molecular 
methods15 178-181. Also, there has not only been an increased crude 
pathogen detection but also higher detection rates of multiple infections 
in the same individual, so called, co-infections182. Despite this, many studies 
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using these molecular methods still do not include healthy controls as 
reference for their interpretation of for example fever aetiology.   
Recently, these sensitive techniques have been applied in research in 
LMICs as well14 15 18 158 and a more complex picture has emerged. In 
general, a high detection frequency has been observed also among healthy 
controls179, comparable to frequencies in symptomatic respiratory and 
gastrointestinal infections. In addition, discoveries of new pathogens have 
been made, in particular viruses like metapneumoviruses, bocavirus and 
new types of coronaviruses, enterovirus and rhinovirus183. However, 
especially in low-income settings, there is not enough evidence to answer 
the question, whether the high detection rates and frequent finding of co-
infections are due to frequent exposure to new pathogens or if the same 
pathogens persist for a longer period of time after the actual symptoms 
have disappeared. Longitudinal sampling after initial detection could help 
to answer this question.  
Despite the lack of a standardised quantification, real-time PCR threshold 
cycle (Ct) values are acceptable estimates of target concentration, for 
example, to distinguish which samples to choose for further molecular 
analyses like sequencing184 or to get a rough appreciation of level of 
malaria parasitaemia185. But in the recent decade Ct values have also 
gained interest for their usefulness in evaluation of symptomatic or 
asymptomatic infections, prediction of disease severity or length of 
hospitalization. The possible utility has been shown both for diarrhoeal 
pathogens186 like norovirus187, rotavirus188 189, and Shigella infections190 as 
well as respiratory tract pathogens like bocavirus, Bordetella pertussis, RSV, 
human rhinovirus, Haemophilus influenzae, and Streptococcus pneumonia163 181 
191-200.  
Conclusion: Smaller reports have been published on real-time PCR 
detection of viruses and the clearance of for example for RSV and 
influenza viruses, but few analyse virus detection simultaneously and 
longitudinally. It is important to include healthy controls for test result 
interpretation of sensitive molecular techniques.    
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Global estimates on child mortality and 
morbidity   
Global estimates on child mortality including LMICs are produced by 
two large groups, the Institute of Health Metrics IHME that produces the 
annual reports on Global Burden of disease in all age groups 
(http://www.healthdata.org/) and the WHO/UNICEF associated Child 
Health Epidemiology Reference Group (CHERG) (www.cherg.org). 
Both groups use a combination of vital registration and verbal autopsy 
data. Where official data is incomplete or even non-existent, statistical 
assumptions and calculations based on data from nearby estimates are 
made. Thus, these two groups use the same types of data but have 
different ways of reaching the mortality estimates why the published 
numbers differ sometimes quite a lot201.  
One commonly used calculation in these types of studies is the population 
attributable fraction (PAF) when assessing the aetiology of a certain disease 
or symptom. PAF defines the contribution of each pathogen to the 
overall load of illness14 180 202 and it can be regarded as the proportional 
reduction in morbidity or mortality if the exposure to the pathogen was 
zero. Hence, these studies estimate the burden of disease on population 
level but do not define a final diagnosis for each individual patient203. 
Hereby, the clinical utility of the information might be limited whereas 
the information is more useful when deciding on an introduction of a 
preventive public health intervention e.g. which vaccine to introduce.  
RSV could serve as an example. RSV has been regarded the second most 
common cause of death globally by the Global Burden of Disease (GBD) 
study, accounting for 27% of deaths in children under 57. However, it 
might be difficult to say that the cause of death actually is the RSV per se, 
i.e. did the child die with RSV rather than from the RSV, or was it a co-
infection or rather a co-morbidity that caused it. A recent retrospective 
analysis of 358 RSV deaths in research studies from different parts of the 
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world (RSV GOLD) shows that around half of the children (30% in 
LMICs and 70% in high-income countries) that die have a comorbidity, 
of which the most common is congenital heart disease, which is 
important to recognize if launching an RSV vaccine204. Looking only at 
the RSV contribution to deaths may miss the target.  
Conclusion: It is crucial to conduct clinical trials that provide regional or 
local data on fever epidemiology, especially in LMICs. Registry data and 
extrapolated figures from studies like the GBD is not enough to 
understand the syndrome of fever, its causes and outcome, in particular 
in young children.  
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AIMS AND OBJECTIVES 
The aim of the thesis was to assess the different components of fever 
diagnosis, management and antibiotic treatment in children below five 
years of age in Zanzibar with a specific focus on interpreting fever 
aetiology based on pathogen detection. The thesis is based on two large 
studies on febrile illness in children, study 1 (paper I) and study 2 (paper II, 
III and IV) 
Main objective study 1 
To determine the effectiveness of malaria RDT used on the first-level 
health care in a low-malaria endemic setting  
Secondary objectives study 1 
• To determine accuracy of malaria RDT versus microscopy 
reading of blood smears (BS) as well as versus parasite detection 
by PCR.  
• To determine the malaria prevalence among fever patients 
presenting at primary health care centres (PHCCs) and primary 
health care units (PHCUs).  
• To determine health worker adherence to RDT results, i.e. 
frequency of prescription of antimalarial drugs in RDT positive 
and negative patients, respectively 
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Main objective study 2 
To determine the causes of uncomplicated fever in children aged 2-59 
months presenting to an outpatient department in Zanzibar.    
Secondary objectives study 2 
• To compare the proportions and quantitative concentrations of 
certain viral and bacterial pathogens in faeces and nasopharynx in 
patients and a control group consisting of asymptomatic, age and 
sampling-time period matched children.  (paper II and III) 
• To evaluate the potential utility of threshold cycle (Ct) values, to 
separate symptomatic from asymptomatic infections.  
• To describe health outcome in patients by follow-up day 14. 
(paper II, IV) 
• To compare clinical IMCI classifications and corresponding 
antibiotic treatment at enrolment according to the new IMCI 
guideline with a final retrospective diagnosis (derived from 
collected clinical, laboratory and radiology data) and its 
corresponding antibiotic treatment (paper II) 
• To compare levels of C-reactive Protein (CRP) in IMCI 
pneumonia patients with and without out X-ray verified 
pneumonia.  (paper II) 
• To analyse the short-term longitudinal dynamics of pathogens 
including clearance, shedding and new infections detected in the 
nasopharynx by using multiplex real-time PCR.  (paper II, IV) 
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MATERIALS AND METHODS  
The laboratory, statistical and epidemiological methods are described in 
detail and referenced in the published articles that are included in the 
thesis (see list of manuscripts above, paper I-IV).   
 
Figure 3. Study sites and shehia distribution in Micheweni (top right) and North A (lower 
right) districts, Zanzibar  
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Study sites and training  
Study 1 and 2 were health facility based observational studies conducted 
in the rural districts of North A in Unguja Island and Micheweni in 
Pemba Island in Zanzibar (Figure 3).  
Each district has around 100 000 inhabitants. In each district there is one 
Primary Health Care Centre (PHCC) which includes an inpatient 
department and laboratory services, e.g. blood transfusion and malaria 
microscopy services. Basic medical treatment services, including malaria 
RDT aided diagnosis of fever patients, are provided in altogether 12 
Primary Health Care Units (PHCUs) per district. If referral is needed, the 
patients are sent to secondary or tertiary level hospitals. Registered 
nurses, with 3 to 4 years of formal training, are responsible for providing 
outpatient care in the PHCUs and clinical officers or assistant medical 
officers in the PHCCs.  
All study personnel were previously trained in malaria case management 
(diagnosis and treatment and the use and interpretation of mRDT) from 
the Zanzibar Malaria Control Programme (ZMCP) (which changed name 
to ZAMEP- Zanzibar Malaria Elimination Programme in 2013) and 
District Health Management Teams of the Zanzibar Ministry of Health 
and Social Welfare. 
In both study 1 and study 2, the participating study health workers had 
training on study-specific procedures as well as the recently adopted 
IMCI guidelines in Zanzibar into which mRDT had been integrated (the 
latter in preparation for study 1 conducted in 2010). All laboratory 
investigations but the mRDT that were performed in study 2 were not 
part of routine IMCI clinical management in Zanzibar but had to be 
specifically introduced, trained and implemented for the study. Prior to 
both studies a pilot study with “dummy runs” were conducted.   
The under-five mortality rate in Zanzibar was 56/1000 live births 
according to the 2015/2016 country wide interview survey Tanzania 
Demographic Health survey- TDHS. This is a clear decrease in 
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comparison to previous measurements with an under 5 mortality rate of 
73/1000 in 2010, 101/1000 in 2004 and 108/1000 in 1996. The decrease 
is like in many places probably not only due to successful malaria 
interventions19 but also introduction of new vaccines as well as increased 
uptake of already existing immunizations and an increased focus on 
maternal and neonatal care.  
Zanzibar and Tanzania follow the WHO recommended immunization 
scheme. During the field studies, EPI immunization programmes against 
diphtheria, pertussis, tetanus (DTP), polio (oral polio vaccination- OPV), 
tuberculosis (Bacillus Calmette Guerin- BCG), hepatitis B, and 
Haemophilus influenzae type B were in place. The estimated coverage of 
three dose of DPT was 91%. The most recent vaccine introductions were 
hepatitis B in 2002 and within the pentavalent DPT-Hepatitis B-Hib 
vaccine formulation, Haemophilus influenzae type B (Hib) immunization 
was introduced in 2009. In 2013, after completion of the present study, 
introduction of the 13 valent pneumococcal vaccine (PCV13) and 
rotavirus vaccine (Rotarix®) were made135 and in 2014, a second dose for 
measles was introduced.  
 
Laboratory training, supervision and logistics  
Laboratory specimens and reagents were sampled, stored and conducted 
according to the manufacturers’ instructions including quality control 
measures.  Around 100 study specific Standard Operating Procedures 
(SOP) covering all aspects of the study, including collection and storage 
of specimens were produced and used as reference for staff at the study 
site. Laboratory analyses of the samples were performed on different 
levels; on the study inclusion site, in the Zanzibar microbiology 
department (Mnazi Mmoja Hospital), in Sweden (the University of 
Gothenburg or the Karolinska Institutet), and in France (Aix Marseille 
Université).  
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All study staff handling laboratory samples were trained on a safe and 
proper sample collection and were further supervised by the designated 
study coordinator. After field trial completion, all samples collected for 
molecular analysis were transported in a controlled environment to 
Sweden by air, either as dried blood spots (DBS) for blood PCR or on 
dry ice (for rectal and nasopharyngeal swabs) or in closed preservation 
agar (for urine cultures). The results from the molecular analyses were 
available months after patient inclusion was finished and thus did not 
affect patient management.  
Ethical considerations  
All studies were conducted in accordance with the principles stated in the 
Declaration of Helsinki and International Conference on Harmonisation-
Good Clinical Practice (ICH-GCP). Before study start, all study 
protocols, case record forms and consent forms were approved by the 
Zanzibar Medical Research Ethical Committee (ZAMREC) and the 
Regional Ethics Committee in Gothenburg and Stockholm for laboratory 
analyses in the Karolinska Institute and the University of Gothenburg. 
All patients or their legal guardians presented a written (proxy) consent 
before study inclusion. All study investigations and medications were 
provided free of charge. Both study 1 and 2 were registered on 
clinicaltrials.gov.  
Specific methods study 1  
Patients aged ≥2 months with a measured fever (electronic axillary 
temperature ≥37·5°C) and/or a history of fever in the preceding 24 
hours were recruited from May to July 2010 by 33 nurses and clinical 
officers with prescription rights from 12 health facilities (6 in the North 
A district and 6 in the Micheweni district). Study exclusion criteria were 
signs of severe disease (as defined by IMCI for children<5 years of age) 
and previous study enrolment in the last 28 days.  
The health facilities were selected for an even geographical distribution 
and based on the skills of health workers in the PHCU. Also, in each 
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study district, one PHCC was included where also mRDTs were 
introduced for the purpose of the study, despite the fact that PHCCs and 
hospitals in Zanzibar use blood microscopy as the routine malaria 
diagnostic tool. All patients below 5 years of age were managed by the 
IMCI guideline and data was documented in a structured IMCI-based 
case record form.  
Malaria analyses  
All patients were subjected to an mRDT, performed and interpreted 
according to the manufacturer’s instructions. The mRDT used in the 
study and deployed by the ZMCP was the Paracheck® detecting P. 
falciparum specific HRP-2 antigen. For those patients who were mRDT 
positive, additional confirmatory analyses with blood microscopy (thick 
smear) and malaria PCR on DBS (filter paper Whatmann ® 3MM) were 
performed. The same confirmatory tests were conducted in 20% of 
randomly selected mRDT negative patients. Blood smears were prepared 
on site, and examined by two independent and experienced microscopists 
blinded to both the mRDT and each other’s microscopy result. In case of 
discordance the samples were subjected to a third and decisive expert 
microscopy reading conducted at Karolinska Institutet.  
Filter papers were dried, stored and transported to Karolinska Institutet 
after field study completion. After DNA extraction, all RDT positive 
samples were analysed with three P. falciparum specific nested PCR methods205 
206. The RDT negative samples were screened in duplicate for human 
plasmodial infection with an 18s quantitative PCR with minor 
modifications207. Samples with discrepant RDT and PCR results were 
subjected to confirmatory nested PCR analysis targeting Plasmodium 
Cytochrome b208. Samples with a negative mRDT but positive 
microscopy/PCR were subjected to PCR analysis of HRP-2 deletion209.  
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Specific methods, study 2 
Study design and participant recruitment, study 2 
In study 2, 2-59 months old children were included that had an acute 
uncomplicated febrile illness (by history and/or electronic axillary 
temperature ≥37·5°C) and were seeking care at a PHCC (Kivunge 
Cottage hospital) in Zanzibar from April to July 2011. Exclusion criteria 
were signs of severe disease (according to IMCI); previous study 
enrolment in the last 28 days; and reported inability to return for follow-
up.  
After enrolment, patients were subjected to IMCI management and treatment 
including an mRDT (SD Bioline-Pf/Pan®). Data was documented in a 
structured IMCI-based questionnaire. There after pre-defined study 
investigations were performed like POC tests, urine cultures, as well as 
multiplex real-time PCR investigations of nasopharyngeal and rectal 
swabs. Some were conducted in all patients and others in patients with 
certain clinical features identified through IMCI management.  
In patients with pneumonia according to the IMCI guidelines, a 
confirmatory chest X-ray investigation was performed to diagnose 
radiological pneumonia (endpoint consolidation). Chest X-rays were 
performed, digitalised and interpreted according to WHO-standards with 
two independent radiologists blinded to each other’s results, with a third 
and decisive expert reading if discordant results148. If suspected severe 
disease on CXR, patients were referred to a paediatric specialist.  
During the field study, recruitment of 167 age- and geography- matched 
healthy controls was performed, defined as children aged 2-59 months 
with no history of diarrhoea, cough, running nose or fever (by history 
and/or electronic axillary temperature <37·5°C) in the preceding ten 
days. Eligible children, maximum two per household, provided 
nasopharyngeal and rectal swabs for real-time PCR-analyses.  
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Figure 4 shows the flow of patients in study 2 (paper II-IV) and 
summarizes all laboratory and radiology examinations performed on 
patients and healthy controls in study 2. Two visits were scheduled during 
the 14-day follow-up and guardians were instructed to come back for 
unscheduled visits if the condition deteriorated. On follow-up day 14, 
25% of patients were randomly selected for paired (day 0 and 14) 
nasopharyngeal swab sampling.  
  
  39 
 
Figure 4. Study flow of patients in study 2 (paper II-IV) 
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Laboratory management, study 2 
All laboratory analyses were performed and interpreted according to the 
manufacturer’s instructions. Malaria analyses were identically performed 
as in study 1 except that in study 2 the mRDT deployed by the time of 
the study the ZMCP was SD- Bioline-Pf/Pan® detecting P. falciparum 
specific HRP-2 antigen and pLDH-Pan.  
In study 2, all patients had malaria RDT, BS and PCR performed. The 
following laboratory tests were performed on day 0, of which some were 
followed by a study intervention. Also, participants with pre-defined 
abnormal laboratory results and/or signs of severe disease were 
discontinued and referred for further clinical management (intervention) as 
described in more detail in paper II.  
Results available at the point-of-care on day 0 
• Throat (swabs): an RDT for qualitative antigen detection 
(positive/negative) of GAS (QuickVue® Dipstick- Strep A test). 
Intervention: A patient with a positive test received penicillin V if not 
already treated with equivalent antibiotic.  
• Whole blood (capillary finger prick): Malaria RDT (SD Bioline 
Pan/Pf®), and CRP (Nycocard®) were performed, the latter with an 
analytical range of 8-200 mg/L. Intervention: Abnormal CRP result: 
>200 mg/L  
• Urine (clean catch): Semi-quantitative biochemical detection of 
leukocyte esterase, nitrite, albumin and erythrocytes. (CombiScreen® 
(7 SYS PLUS)). Rapid detection of pneumococcal antigen in urine 
(BINAX NOW®). Intervention: none 
Results available within a couple of days after inclusion 
• Whole blood (capillary finger prick): Malaria microscopy (first 
reading), Complete Blood Count (CBC) (Sysmex® KX-21). 
Intervention: BS positive for malaria, not previously detected received 
antimalarial treatment. Intervention: Abnormal laboratory result: white 
blood cell count >35*10^9/L; platelet count: <20*10^9/L; 
Haemoglobin: <6 g/dL 
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• Urine (clean catch): Preserved in 2-8°C, sent for culture to the 
microbiology laboratory and followed WHO standards210 211. 
Intervention: Patients with positive urine cultures were treated with an 
antibiotic corresponding to the susceptibility pattern.   
Test results available after field study completion  
• Urine culture: Colonies from urine cultures with significant growth 
sent for external quality control for verification of species and 
antibiotic susceptibility pattern. (Gothenburg, Sweden) 
• Whole blood/dried blood spots: 
o Detection of malaria: Equal to study 1. Malaria microscopy 
(second and third reading) and PCR. (Zanzibar/Stockholm, 
Sweden).  
o Detection of Rickettsia spp: Quantitative real-time reverse transcription 
PCR (qRT-PCR) by using a Rickettsia genus-specific qRT-PCR 
targeting the gltA gene of Spotted fever group Rickettsia spp 
and an R. felis-specific qRT-PCR targeting the bioB and orfB 
genes212. qRT-PCR to detect Typhus group Rickettsia spp. 
targeting the hypothetical protein encoding gene213. (Aix, 
France) 
o Detection of dengue virus (DENV), West Nile virus (WNV), Rift 
Valley fever virus (RVFV), and chikungunya virus (CHIKV) by 
PCR: RNA was extracted from DBS (n=84) and screened by 
a beta actin PCR for RNA quality control. The dengue PCR 
semi-nested PCR has been published by Harris et al214. In 
house real-time PCRs were used for detection of RVFV, 
WNV, and CHIKV215. (Stockholm, Sweden) 
• Nasopharyngeal and rectal swabs:  
o Sampling: Flocked nasopharynx and rectal swabs were 
sampled and preserved in a standardised manner and stored 
in a controlled temperature of <-70˚C.  
o Real-time PCR: Automated nucleic acid extraction was 
followed by multiplex, multi-targeting real-time PCR 
amplification of the following respiratory pathogens: 
adenovirus, bocavirus, coronavirus (229E, OC43, HKU1, 
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NL63), enterovirus, metapneumovirus, influenza virus (A and 
B), measles virus, parechovirus, parainfluenza virus (1-3), 
respiratory syncytial virus (RSV), rhinovirus, Bordetella pertussis, 
Chlamydophila pneumoniae, Haemophilus influenzae, Mycoplasma 
pneumoniae and Streptococcus pneumoniae216 217 and the following 
diarrhoeagenic pathogens: adenovirus, adenovirus (40/41), 
astrovirus, norovirus genogroup 1 and 2 (GG1 and GG2), 
rotavirus, sapovirus, Campylobacter jejunii, Enterotoxigenic 
Escherichia coli (ETEC)-estA, ETEC-eltB, Salmonella spp, Shigella 
spp, Vibrio cholerae, Yersinia enterocolitica, and Cryptosporidium 
parvum/hominis.  For further analysis, the PCR results were 
recorded as detection (positive or negative) and for reactive 
samples also as the Ct (threshold cycle) value.  
o Sequencing of enterovirus/rhinovirus in the 
nasopharynx: When both enterovirus and rhinoviruses were 
positive and there was a >10 cycle difference in Ct values, the 
result was in favour of the pathogen with the lowest Ct value. 
Otherwise sequencing was performed for species 
identification217. Similarly, sequencing was performed if the Ct 
value was >4 cycles lower on day 14 than day 0 (indicating a 
probable new infection)  
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Data management and statistical analysis  
Sample size calculations and data entry 
Sample size calculations were performed in study 1 based on the primary 
endpoint, adherence to mRDT results with the assumption that around 
10% of the RDT negative patients would be prescribed ACT in Zanzibar. 
Study 2 was exploratory in nature, which precluded a sample size 
calculation. However, a sample of 650 patients and at least 150 controls 
was considered sufficient to obtain a representative classification of fever. 
After double data entry into CSPro, further validation of data was 
performed in Microsoft Excel®. Thereafter data was exported to 
STATA® (10, 12 and 14) where all statistical analyses were performed.  
Statistical analysis study 1 
P-values <0.05 were considered statistically significant. Frequencies, 
proportions and odds ratios (ORs) were calculated with 95% confidence 
intervals (CI) as appropriate. The fact that blood sampling for malaria 
microscopy and PCR among RDT negative patients only included a 
random sample of 20% was accounted for. Thus, the absolute numbers 
of observations were multiplied by the factor 5.14 and 5.01 in all 
calculations on the secondary endpoints that compared mRDT against 
microscopy and PCR (sensitivity, specificity, negative predictive value 
(NPV) and positive predictive value (PPV).  
Statistical analysis study 2 
P-values <0.05 were considered statistically significant. Frequencies, 
proportions and odds ratios (ORs) were calculated with 95% confidence 
intervals (CI) as appropriate. For independent samples, Fisher’s exact test 
and exact binomial test were used for binary data and proportions, two-
sample t-test for mean comparisons, and Mann-Whitney-U test for 
median comparisons. The association between CXR-confirmed 
pneumonia and multiple variables was assessed with logistic regression. 
The cut-off values for inflammatory biomarkers (CRP and white blood 
cell count (WBCs)) were chosen to concur with published literature218 
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(paper II and III). In paper IV, detection and pathogen load (Ct value) were 
analysed by comparing paired multiplex real-time PCR data on 
nasopharyngeal swabs sampled from a sub-group of randomly selected 
patients in the parent study collected on study inclusion (day 0) and on a 
clinical follow-up after 14 days. The exact sign tests were used for binary 
data and paired t-test for the comparison of means.  
Establishing a Ct cut-off value 
The PCR results from the nasopharyngeal (paper II) and rectal swabs 
(paper III) collected from patients and healthy controls were analysed. In 
addition to comparing detection rate proportions and corresponding 
ORs, the potential utility of pathogen load in terms of real-time PCR 
threshold cycle (Ct) values to separate symptomatic from asymptomatic 
infections was evaluated. The Ct value is inversely related to the pathogen 
load in each specimen. For some pathogens, a Ct value cut-off was 
identified that optimally distinguished between patients and healthy 
controls, as follows.  
Ct values from nasopharyngeal (paper II, supplement) and rectal qPCR (paper 
III) were compared in a logistic regression with patient/control as 
dependent variable and age (continuous), and gender (binary) as well as 
Ct values (continuous) as multiple independent variables. This analysis 
first included Ct values for all agents (with negative variables given Ct 
value 45). Factors not independently associated with symptoms were 
omitted in a step-wise manner. The cut-off was determined by using the 
highest balanced accuracy value (BCR) defined as follows: (BCR=0.5 x 
(sensitivity + specificity)). Agents independently associated with disease were 
classified as more likely causes of fever. Independent agents had either a 
difference in crude detection rate between patients and controls or 
proportions with Ct values below the above defined Ct value cut-off  
Determining final cause of fever and infections that require antibiotics 
Individual final patient diagnoses or causes of fever were retrospectively 
established by two paediatricians based on all available clinical and 
laboratory data in order to evaluate the utility of IMCI for identification 
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of infections presumed to require antibiotics. The final diagnoses were 
generated from pre-defined criteria based on available clinical and 
radiology/laboratory data from day 0. Subsequently, these criteria were 
applied to each patient.  
The diagnoses were categorized into three groups:  1) more probable 
causes of fever, 2) less probable causes of fever, and 3) “no verified 
aetiology”. If a more probable diagnosis was identified, all less probable 
diagnoses were ignored for that patient, but within one group each 
patient could receive more than one diagnosis. Multiple final causes of 
fever were possible. Infections requiring antibiotics were defined 
retrospectively as those final diagnoses presumed to benefit from 
antibiotics based on WHO recommendations219. The association between 
these infections and both actual antibiotic prescription as well as IMCI 
indication for antibiotics was assessed.   
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RESULTS AND DISCUSSION  
 
Malaria prevalence during and after the rain 
season in Zanzibar  
Out of 20423 patient consultations performed in the 14 included health 
facilities, 3890 (19%) were included in study 1 of which 1822 (46,9%) 
were children <5 years of age and 528 (13,6%) were 5-14 years of age. 
Hence, more than 60% of the included children were aged below 15 years 
which corresponds fairly well with the demographic structure of Zanzibar 
where official statistics claim that 45% of the population are below 15 
years old.  
In study 2, out of 826 children screened for eligibility, 677 children were 
enrolled of which 42% (286/677) had a measured axillary temperature of 
≥37.5°C, similar to paper I, which had a corresponding figure of 43% 
(1539/3550). (Figure 4). These results are similar to previous research 
where 30-80% of patients with a reported fever actually have a measured 
temperature at the time24 42-46.  
Both study 1 and 2 were conducted during the main malaria season in 
Zanzibar, which occurs in the end and directly after the rain season. Yet, 
malaria prevalence by mRDT among febrile children <5 years of age was 
low, 2.0% (36/1822) and 0.3% (2/677) in paper I and II, respectively. 
These results are in line with a recent paper by Björkman, Shakely et al 
showing data from Zanzibar where in 2010, positivity rate among 
patients tested at the PHCUs for malaria in North A and Micheweni was 
0.8% and 1.7%, respectively in 2010 and 0.4% and 0.8%, respectively in 
2011 which also were the years that study 1 and 2 were conducted. 
Moreover, in 2002, half of the malaria positive patients were below 5 
years old while the same proportion was 17% in 201519.  
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Overall positivity rate of mRDT was 121/2889 (3.1%). mRDT positivity 
was significantly associated with both history of travel (OR 3.27) as well 
as absence of ITN/LLIN use (OR 4.78). RDT positive children had 
significantly higher axillary temperature than RDT negative patients 
(38.3°C versus 37.4 °C; p<0.001). Children aged 5-14 years had the 
highest malaria prevalence by mRDT of 6.1% (32/528) (paper I), in 
comparison with the overall malaria prevalence; 3.1% (121/3889). These 
factors indicate the demographic transition where the highest malaria 
positivity rate is seen in school aged children rather than younger children 
do in Zanzibar and other African countries19 220. The reasons are probably 
mainly behavioural such as the fact that that older children spend more 
time outdoors in the evening and are thus less prone to lie under a 
mosquito net. Older children also travel more than younger do which is a 
risk factor for malaria infection in both mainland Tanzania102 and 
Zanzibar19.  
Malaria control interventions focus primarily on protecting the preschool 
children from malaria since they are the most vulnerable.  Interventions 
like for example bed net distribution are probably more effective in 
younger than in older children.  If targeting malaria infections in school 
children, other new or established intervention strategies might be 
considered, like for example mass testing and treatment (MTAT), or 
preventive chemotherapy like mass drug administration (MDA) and 
vaccination220. However, in two recent randomised controlled trials 
conducted in Zanzibar neither MTAT221 nor MDA222 had an impact on 
overall transmission.    
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Malaria RDT test performance.  
In study 1 the HRP-2 based mRDT (Paracheck®) performed mediocrely 
with a sensitivity of 76.5% (95% CI 69.0–83.9%) against PCR and 78.6% 
(95% CI 70.8–85.1%) against microscopy (expert reading). Specificity was 
>99%. The diagnostic performance was below the result from the 2009 
WHO report that compared different brands for malaria RDTs (round 
2). It showed a good sensitivity (97.5%) of Paracheck® for high 
parasitaemias but only 54% for parasitaemias at 200 parasites/uL223. One 
reason for false negative results could be the changes in the genes that 
code for the HRP-2 protein, which is the malaria antigen detected in the 
mRDT224. In study 1, all samples with discordant results between mRDT 
and microscopy and/or PCR were screened, but no so-called P. falciparum 
HRP-2 deletions were detected. In contrast, a recent report from Eritrea 
showed that 80% of the parasites detected had these HRP-2 deletions 
and subsequently most of them were also HRP-2 RDT negative225.  
Another reason for a false negative test is the so called prozone effect which 
is a false negative result due to an excess of malaria antigen that exists for 
HRP-2 based tests only, since three patients with high parasitaemia on 
microscopy were mRDT negative226, although the prozone effect has 
mainly been described for hyperparasitaemias (defined as >250 000 
parasites/uL or 5% of the erythrocytes infected), which none of the 
patients included in study 1 had. The prozone effect has not been shown 
for pLDH or aldolase mRDTs227.  
The last and most probable reason is the operator factor.  Most of the 
mRDT negative and microscopy positive patients came from the same 
health facility. This further sheds light on the fact that for all types of 
interventions, supervision and training is key228 229. The low sensitivity in 
our study is in contrast to research by Batwala et al who showed that 
HRP-2 based RDTs like Paracheck® outperform both health centre 
malaria microscopy as well as expert microscopy in sensitivity and 
specificity, both in high endemic and low endemic settings230-232. Others 
have confirmed the results of study 1 with a low sensitivity of HRP-2 
RDTs and conclude that in an area where malaria is decreasing, HRP-2-
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based detection of malaria is suboptimal233 due to an unacceptable high 
number of false negatives79 whereas false positive mRDT results are more 
of a problem in high endemic areas78 234. The false positive tests might be 
due to the well-known prolonged antigenaemia detected by the HRP-2-
based tests for up to a month after a P. falciparum infection235.  
Out of the 124 patients that were positive for P. falciparum malaria by 
PCR, 9 infections were not found with malaria microscopy (paper I). 
Ramesh et al also recently published an article on children with fever of 
unknown origin in Uganda, which showed that around 50% of patients 
had malaria detected with metagenomic techniques whereas only 10% 
were positive by microscopy236. This could call for more sensitive 
molecular techniques to replace microscopy as gold standard reference in 
malaria elimination settings as some research groups propose231.  
Yet, many children residing in high malaria endemic areas may have 
asymptomatic parasitaemia with doubtful clinical relevance. Some argue 
that the level of parasitaemia that defines a clinical malaria case should be 
different depending on both the age of the patient as well as the level of 
malaria endemicity in the area where the patient resides. The lower the 
malaria prevalence, the lower the threshold for regarding a parasitaemia a 
true infection. Also, low parasitaemias may play a more important role in 
spreading the infection than previously thought in lower endemic or pre-
elimination areas73 74.  Hence, in research studies in high endemic areas 
microscopy could be preferable as gold standard whereas more sensitive 
tools like PCR might be better in low endemic settings.  
Despite the mentioned disadvantages of mRDT, most experts nowadays 
would still advocate the use of mRDTs before health care facility 
microscopy in routine clinical care228. Furthermore, the mRDT in study 2 
performed well for identification of P. falciparum where there was a 100% 
concordance between the results of PCR, BS and mRDT. Importantly, 
there were no false positive mRDT tests in the malaria negative patients. 
This further supports the introduction of the SD Bioline® Pan/Pf which 
the Ministry of Health in Zanzibar decided on based on the results from 
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study 1.  Also, the test performance of the SD Bioline® Pan/Pf in round 
2 of the WHO report from 2009 was excellent223.  
The finding that P. malariae might play a greater role could also be a 
retrospective support for the SD Bioline® Pan/Pf introduction since that 
test is also detecting non-falciparum malaria. Importantly, two out of 116 
malaria infections in paper I were positive for P. malariae by PCR. The 
proportion of P. malariae in the clinical and asymptomatic malaria 
infections in East Africa have increased in the last decade19 237. P malariae 
is an infection that could remain dormant in blood cells for a long time 
(years). Therefore it may constitute a higher share of the detected 
parasites in blood. Especially if investigations include PCR that could 
detect low parasitaemias below the threshold of both microscopy and 
malaria RDT. Also the fact that co-infections between P. falciparum and 
other species like P. ovale and P. malariae are common might indicate that 
these infections were underdiagnosed before237. A recent report highlights 
the low performance of existing mRDTs to detect non-falciparum 
species, in particular P. malariae and P. ovale 238. With increasing 
proportions of non-falciparum species among malaria patients, a higher 
and more coordinated focus on their diagnosis and management is 
needed.  
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Health worker adherence to malaria RDT 
results  
Paper I showed that health worker adhered to mRDT results in 99.9% of 
cases, both with or without the IMCI guideline. Antimalarial treatment 
was prescribed to all mRDT positive patients but only to 3/3768 (0.08%) 
of patients that had a negative mRDT. This high adherence rate is in 
contrast to other similar studies, that exhibit lower adherence to both 
negative and positive mRDTs239, in some as little as 80% of mRDT 
positive patients and over 30% of mRDT negative receive antimalarials240.  
A meta-analysis of similar studies showed that health providers were 
more likely to adhere if the result was according to their expectations. 
Adherence was also higher if the RDT had already been integrated into 
standard care and if there was a clinical management strategy for the 
mRDT negative patients229. Zanzibar has in the recent two decades had a 
comprehensive and versatile malaria control campaign, which probably is 
one explanation for this.  
Indeed, scientists argue that the great problem in malaria endemic settings 
is the overprescription of antimalarials. However, underprescription is 
likely underestimated240. It also matters where the test-and-treat package 
is implemented. For example, RDTs introduction to a part of the private 
drug shop sector in Ghana was successful and increased accurate 
antimalarial treatment from 27% to 74% in the intervention arm where 
patients were provided free mRDTs241. Specific studies on the 
performance of mRDT integration within the IMCI have rarely been 
reported before65. mRDT integration within the IMCI did not affect 
adherence in our study, and thus was optimal.  
A false positive mRDT is sometimes regarded a substantial clinical risk by 
misleading the clinician away from diagnosing the co-existing bacterial 
infection242. However, the opposite has also been shown. In Senegal, the 
National Malaria control programme introduced a new fever 
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management protocol in 2007 that guided the health care worker in a 
febrile patient to first consider “other causes of fever” like upper 
respiratory tract infections (URTI) or pneumonia. The results of a trial 
attached to this intervention showed that the guideline excluded too 
many patients with malaria from receiving an mRDT at their first visit243, 
most likely due to the fact that the clinical picture of malaria is typically 
unspecific and can include both respiratory tract and gastrointestinal 
symptoms.  
The PRIME trial evaluated the effect of a patient centred health 
intervention package with the aim to increase quality of care and better 
outcomes244. It showed that accurate antimalarial prescription was similar 
in the intervention arm and the control arm with almost a fourth of the 
patients with a positive malaria test that did not receive antimalarials245. 
The above mentioned reports exemplify that designing a clinical fever 
management intervention is complicated and poses a risk of 
undertreatment with antimalarials.  
Distinguishing between cause of illness and 
asymptomatic infection 
Study 2 was the first comprehensive study on non-severe febrile illness in 
children in Africa using a healthy control group for comparison of PCR 
results. A total of 22257 analyses were conducted for the detection of 36 
pathogens, of which a majority was detected by using molecular analyses. 
Figure 4 shows the flow of patients in study 2. Median detection was 
three pathogens (range 0-10) per patient and only eight patients had no 
microbe detected. There was a high detection rate of pathogens detected 
by real-time PCR both in the 677 included patients and the 167 healthy 
controls (Table 1).  
The crude detection of a pathogen nucleic acid in a sample does not 
always indicate cause of disease. This is of particular importance in low-
income countries, where children due to poor sanitary conditions or 
overcrowding are more likely exposed to multiple pathogens. Thus, 
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understanding aetiologies and interpretation of test results require analysis 
of pathogens from both ill and healthy individuals. In the recent decade 
four large multicentre studies from LMICs on infectious disease aetiology 
in children below 5 years of age that use molecular techniques and also 
include a control group. Two study diarrhoeal disease; firstly the Global 
Enteric Multicentre Study (GEMS) on moderate to severe diarrhoeal 
disease20 and secondly the multi-country Malnutrition and Enteric disease 
(MAL-ED) study that analysed enteropathogen contribution to 
community diarrhoeal disease in the first two years of life by comparing 
diarrhoeal and non-diarrhoeal samples in a longitudinal birth cohort246 12. 
Both GEMS and MAL-ED later re-analysed their samples using 
quantitative measures of PCRs15 178 186. 
 Two other studies report the causes of severe/hospitalized pneumonia in 
patients with WHO defined endpoint radiological pneumonia; the study 
from the GABRIEL-network (Global Approach to Biological Research, 
Infectious diseases and Epidemics in Low-income countries)16  as well as 
the Pneumonia Etiology Research for Child Health (PERCH) study 
(published in July 2019)13 14. All these studies use the population 
attributable fraction (PAF) to define the contribution of each pathogen to 
the overall load of illness in the population studied12 14 180 202 246 and similar 
to study 2 the results from the PERCH study also will define a final 
diagnosis for each individual patient203.  
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Respiratory tract pathogen detection in patients 
and healthy controls  
Real-time PCR conducted on nasopharyngeal swabs showed that 98% of 
patients and 93% of controls were positive for one or more pathogens 
(paper II). More than one pathogen was detected in 88% of sampled 
patients and 83% of sampled controls.  
Influenza A and B virus, RSV and enteroviruses were significantly more 
common in patients than controls, with the opposite for rhinovirus and 
coronavirus which were more common in controls (Table 1).  
Other studies from the African region comparing healthy controls and 
patients with fever and/or respiratory symptoms like URTI and 
pneumonia have shown similar results with high detection rate in healthy 
individuals13 16 247-249. From previous literature, the pathogens that have 
emerged as significantly more common in cases than controls are 
influenza A and B virus, metapneumovirus, parainfluenza virus and in 
particular RSV13 16 180 247-255. For adenoviruses, bocavirus, rhinoviruses and 
coronaviruses, which are often common in both cases as well as controls 
there are conflicting results.  
Some aetiology studies choose not to include the analysis of rhinoviruses 
at all248. Despite this, both the GABRIEL and PERCH studies point out 
rhinovirus as a common cause of hospitalised pneumonia13 16. Also, the 
GABRIEL study had a strong association with being a case for influenza 
A (adjusted OR 55) in line with the results from paper II (Table 1; OR 
5.1). Interestingly, the PERCH study could not show the same strong 
association since there was a generally low detection (<5%) of influenza 
A and B viruses.  
 
Table 1. Real-time PCR pathogen detection and Ct values on nasopharyngeal and  
rectal swabs from patients and healthy controls. Modified from paper II and III. 
Pathogen 
Patients 
n positive 
(%) 
Controls  
n positive 
(%) 
Unadjusted 
OR  P
a 
Ct value 
median 
(patients/ 
controls) 
Pb 
Nasopharyngeal swab 
PCR (n sampled) 
 
672 
 
166 
    
Viruses   
    
Adenovirus  12 (1.8%) 1 (0.6%) 3 0.48 29.5/36.6 0.42 
Bocavirus 20 (3.0%) 4 (2.4%) 1.2 1.0 36.7/38.3 0.19 
Coronavirus 52 (7.7%) 23 (14%) 0.5 0.02 31.9/31.7 0.33 
Enterovirus 58 (8.6%) 1 (0.6%) 15.6 <0.0001 36.0 /35.4 0.81 
Metapneumovirus 11 (1.6%) 0 (0%) . 0.13 28.6/0 . 
Influenza B virus 94 (14%) 4 (2.4%) 6.6 <0.0001 27.8/34.7 0.0083 
Influenza A virus 58 (8.6%) 3 (1.8%) 5.1 0.001 27.3/39.0 0.35 
Morbillivirus 5 (0.7%) 0 (0%) . 0.6 37.8/0 . 
Parechovirus 5 (0.7%) 0 (0%) . 0.6 32.6/0 . 
Parainfluenza virus 10 (1.5%) 1 (0.6%) 2.5 0.7 24.9/23.8 0.75 
Respiratory syncytial 
virus (RSV) 174 (26%) 27 (16%) 1.8 0.008 26.8/33.7 0.0025 
Rhinovirus 105 (16%) 48 (29%) 0.5 <0.0001 30.7/28.7 0.022 
Bacteria       
Bordetella pertussis 5 (0.7%) 0 (0%) . 0.59 30.2/0 . 
Chlamydophila 
pneumoniae 8 (1.2%) 0 (0%) . 0.37 40.4/0 . 
Haemophilus influenzae 515 (77%) 130 (78%) 0.93 0.76 30.2/29.4 0.023 
Mycoplasma pneumoniae 2 (0.3%) 1 (0.6%) 0.5 0.49 38.2/37.9 1 
Streptococcus 
pneumoniae 587 (87%) 137 (83%) 1.5 0.128 27.3/26.9 0.08 
Rectal swab real-time 
PCR (n sampled) 164 165         
Viruses             
Adenovirus (any) 45 (27%) 53 (32%) 0.79 0.4 38.2/39.3 0.05 
Adenovirus 40/41 10 (6.1%) 6 (3.6%) 1.71 0.44 36.6./35.0 0.66 
Astrovirus 4 (2.4%) 1 (0.6%) 4.07 0.37 19.9/31.5   
Norovirus GI 1 (0.6%) 1 (0.6%) 1       
Norovirus GII 33 (20%) 4 (2.4%) 10.1 <0.0001  25.1/26.9 0.28 
Rotavirus 16 (9.8%) 3 (1.8%) 5.8 0.003 24.4/26.0 0.5 
Sapovirus 13 (7.9%) 7 (4.2%) 2.09 0.18 25.6/28.3 0.5 
Bacteria             
Campylobacter 58 (35%) 54 (33%) 1.11 0.73 31.8/33.3 0.12 
Vibrio cholerae 1 (0.6%) 0 (0%)   -     
ETEC-eltB 71 (43%) 76 (46%) 0.91 0.74 31.3/34.6 0.002 
ETEC-estA 54 (33%) 39 (24%) 1.62 0.07 32.6/37.3 0.0001 
Salmonella 9 (5.5%) 4 (2.5%) 2.32 0.26 42.2/40.6 0.22 
Shigella 56 (34%) 54 (33%) 1.08 0.82 29.2/34.5 <0.0001 
Yersinia 0 (0%) 0 (0%)         
Protozoa             
Cryptosporidium 49 (30%) 18 (11%) 3.45 <0.0001 32.1/36.8 0.0009 
ETEC: Enterotoxigenic Escherichia Coli; OR, odds ratio; PCR: Polymerase Chain Reaction; 
RDT: Rapid Diagnostic Test
 
a Fisher’s exact test.  
b Mann-Whitney U test displayed for agents with a total of >10 positives samples. 
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Enterovirus was shown to be undoubtedly associated with fever in study 
2 (Table 1; OR 15.6). Hercik et al reported enteroviruses in 15% of their 
febrile patients185 but besides enteroviruses have rarely been reported 
from fever studies in Africa. One reason could be that enteroviruses 
normally do not cause respiratory symptoms but are instead the cause of 
undifferentiated fevers256.  
Most previous studies that apply nasopharyngeal PCR include patients 
with acute respiratory but not fever without respiratory symptoms. In 
agreement, rhinovirus does not commonly elicit a fever and therefore can 
be more common in afebrile patients. Also enteroviruses could cross 
react with rhinoviruses in the real-time PCR reaction due to the RNA 
sequence similarities. In previous studies, it is often unclear how 
enteroviruses and rhinoviruses are distinguished.   
In study 2 separate real-time PCR assays were used for enterovirus and 
rhinovirus, and sequencing was performed for further characterization if 
the Ct value difference was less than ten cycles. The results showed that 
the most common rhinovirus type was type C (12 out of 15 patients 
(80%) with final result rhinovirus). Human rhinovirus type C was 
discovered in 2007257 by the application of molecular techniques (it is 
difficult to propagate in cell cultures) and might be associated with more 
severe symptoms than other rhinoviruses. Recent research in the SSA 
region show that rhinoviruses are common and in particular type C using 
both real-time PCR techniques258 and metagenomics236.  
A limitation of study 2 was the age difference between healthy controls 
and patients. We decided to include healthy controls from the community 
and not from the same health facility where patients are recruited, as 
some studies choose to do16. This was to make sure that recruitment of 
healthy controls was not impeded by a lack of participants and to get a 
geographically representative sample from the whole catchment area of 
the health facility. However, the limitation was subsequently that the 
controls recruited were median 10 months older than the patients (paper 
II-IV), which may have been avoidable if we had actively recruited from 
the health facility where the study was conducted.  
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Another important question when choosing control subjects for studies 
on infectious disease aetiologies, is whether controls should be allowed to 
be symptomatic or not. Study 2 included only asymptomatic controls 
both for rectal swab and nasopharyngeal sampling in line with the 
GABRIEL and GEMS studies.  There is a risk of selection bias, since it 
could particularly be difficult to recruit infants without a history of fever, 
ARI symptoms or diarrhoea in the last 2 weeks. Therefore, as decided in 
the PERCH study, community recruited controls with respiratory 
symptoms could be regarded as more representative for the general 
population as long as they do not qualify to be a case259. This risk might 
be more obvious in a study on pneumonia than fever.  
Influenza B and RSV were more common in patients than healthy 
controls and patients also had significantly lower median Ct values (Table 
1). Interpretation of Ct values as a proxy for pathogen load of 
simultaneously detected multiple pathogens had not systematically been 
performed before the conduct of study 2, and in particular not in LMICs. 
However, a distinct Ct value cut-off to distinguish disease from 
asymptomatic infections could not be defined for any nasopharyngeal 
agent why all detected pathogens (with Ct value <40) were included in 
the analysis.  
The PERCH study which included children 1-59 months with severe and 
very severe pneumonia according to the WHO definition, recently 
reached a similar conclusion. It showed that there was a significant 
difference in mean Ct value for adenovirus, parainfluenza virus 1 and 3, 
RSV, and rhinovirus253 between the following groups; asymptomatic 
controls, patients with respiratory signs and pneumonia cases. However, 
due to substantial overlap in viral load distribution a cut-off to distinguish 
between pneumonia and upper respiratory tract infection could not be 
identified for any virus.  
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Diarrhoeal pathogen detection and Ct value cut-
offs  
It is sometimes argued that patients with gastroenteritis should not be 
included in a study on fever aetiologies. Yet, we considered it important 
to include patients with diarrhoea as well. First of all, diarrhoea is the 
second largest killer in children younger than five years260. Secondly, we 
thought that patients with diarrhoeal disease should not be excluded 
considering the exploratory nature of study 2 for it to be as unbiased as 
possible and include the whole spectrum of patients that a clinician 
encounters on the first level of health care.  
Indeed, in the MAL-ED study described above, fever was the symptom 
associated with the most important diarrhoeal pathogens and could then 
be regarded as a marker of more severe illness12. A fourth of the patients 
(n=176) in our study had diarrhoeal symptoms which is in concordance 
with other clinical studies in the area158. Of these 176 patients, 63% 
(n=111) reported ≥3 stools/24 hours which was also the criterion for a 
gastroenteritis diagnosis in the interpretation of final diagnosis.  
In paper III, we analysed the real-time PCR-results on rectal swabs from 
children with or without diarrhoea.  Similarly to nasopharynx PCR, a high 
detection rate was seen with 95% of patients and 87% of controls that 
were positive for one or diarrhoeal more pathogens. More than one 
pathogen was detected in 36% of the 164 sampled patients and 30% of 
the 165 sampled healthy controls. Cryptosporidium, rotavirus and norovirus 
GG2 were significantly more common in patients than controls.  
In addition to comparing detection rates, and similar to the analysis 
performed for nasopharyngeal PCR, we aimed to evaluate the potential 
utility of pathogen load in terms of real-time PCR threshold cycle values 
to separate symptomatic from asymptomatic infections. Cryptosporidium, 
ETEC eltB, ETEC estA and Shigella patients had a significantly higher 
median Ct value (pathogen load) than controls.  
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In contrast to nasopharynx PCR, a cut-off in Ct value could be defined 
by a two-step analysis for rectal swab PCR. The pathogens considered 
most important causes of diarrhoea, when frequencies and Ct value cut-
offs in patients versus controls were applied were Cryptosporidium (Ct cut-
off <35), Shigella (Ct cut-off <30), norovirus GG2 (Ct cut-off <40), 
ETEC-estA (Ct cut-off <31), and rotavirus (Ct cut-off <40).  
When the cut-offs were used, the five most important diarrhoea agents 
among patients were Cryptosporidium (25%), Shigella (20%), ETEC-estA 
(16%), norovirus GG2 (19%), and rotavirus (9.1%). Ct values of 40-45 
are normally the cut-off limit for the PCR- reaction but values in that 
range are often regarded too high to be clinically relevant and are 
potentially only finding the subclinical infections187. The Ct value cut-offs 
that emerge from this analysis are in the same range as previous studies. 
In general the cut-offs end up in between 30-35 for both diarrhoeal187 188,  
as well as respiratory tract198 199 pathogens and malaria17 185. 
The results from paper II and paper III were confirmed by the Global 
burden of disease study that in particular point out rotavirus as the most 
important pathogen and cause of death6. The GEMS study concluded 
that in addition to rotavirus preventive interventions specifically targeting 
Cryptosporidium, ETEC-estA, Enteropathogenic E.coli (EPEC) and Shigella 
would substantially reduce mortality and hospitalization of diarrhoea15.  
The MAL-ED study, that focused on diarrhoeal disease in the 
community which might be more comparable to the non-severely ill 
febrile patients in study 2, showed that norovirus GG2, rotavirus, 
astrovirus, Campylobacter spp and Cryptosporidium spp were the highest 
contributors to diarrhoeal disease in the first two years of life whereas 
Shigella spp, Cryptosporidium spp and ETEC-estA caused the most severe 
diarrhoeal episodes. Interestingly, in the sites where rotavirus vaccination 
was introduced, the contribution of rotavirus to diarrhoeal disease was 
negligible.  
The finding that norovirus was one of the highest contributors to 
diarrhoeal disease both in MAL-ED as well as study 2 might support the 
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fact that noroviruses typically do not cause severe symptoms in children. 
Moreover, GEMS included more severely ill patients and noroviruses 
were not as common in that study. Cryptosporidium seems to be common 
but a previous study in Zanzibar found in contrast only a few patients 
that were infected. This highlights the need for correct choice of primers 
for the PCR reaction261. The primers that we chose262 detect the most 
common species of Cryptosporidium spp, i.e. C. parvum and C. hominis263. In 
both the GEMS and the MAL-ED study, application of PCR increased 
the overall pathogen detection with 50-100% in comparison with 
traditional microbiology techniques that were used in the initial 
publications. Hereby, the detection of in particular shigellosis and 
sapovirus was increased with molecular techniques178 186. 
Causes of febrile illness  
Study 2 was the first study in Africa on uncomplicated febrile illness that 
both applied a comprehensive laboratory panel as well as including a 
healthy control group. Paper II-IV show the result of a carefully thought 
through approach where in each individual patient a final diagnosis/cause 
of fever was determined (Table 2). Before this study-specific 
interpretation, the most common detected pathogens were Haemophilus 
influenzae, Streptococcus pneumoniae, RSV, influenza A or B virus and 
rhinoviruses in patients and Haemophilus influenzae, Streptococcus pneumoniae, 
rhinoviruses, RSV, and coronaviruses in healthy controls (Table 2).  
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Table 2. Final diagnoses versus pathogen detection in patients and healthy controls. 
Pathogen 
Patients 
n positive 
(%) 
Controls  
n positive 
(%) 
Final cause of 
fever 
n (%)  
 
Total number patients/controls 
 
677 
 
166  
 
677 
Pathogen/diagnosis 
  
 
Respiratory syncytial virus (RSV) 174 (26%) 27 (16%) 166 (25%) 
Influenza A/B virus  151 (22%)   5 (3.0%) 151 (22%) 
Rhinovirus 105 (16%) 48 (29%) 71 (10%) 
Enterovirus 58 (8.6%)  1 (0.6%) 58 (8.6%) 
Group A Streptococci 89 (13%) NA 45 (6.6%). 
Radiologically verified pneumonia 42 (6.2%) NA 42 (6.2%) 
Coronavirus  52 (7.7%) 23 (14%) 30 (4.4%) 
Shigella spp 55 (8.1%) 54 (33%) 29 (4.3%) 
Cryptosporidium spp 49 (7.2%) 18 (11%) 26 (3.8%) 
Caliciviridae 47 (6.9%) 12 (7.2%) 22 (3.2%) 
Enterotoxigenic E. Coli*  54 (8.0%) 39 (23%) 22 (3.2%) 
IMCI Otitis 21 (3.1%) NA 21 (3.1%) 
Rotavirus 16 (2.4%) 3 (1.8%) 11 (1.6%) 
Urinary tract infection/significant 
growth 16 (3.5%) NA 11 (1.6%). 
Metapneumovirus 11 (1.6%)    0 (0%) 8 (1.2%) 
Bocavirus 20 (3.0%)  4 (2.4%) 8 (1.2%) 
Adenovirus (ARI) 12 (1.8%)   1 (0.6%) 8 (1.2%) 
Campylobacter spp 58 (8.6%)  54 (33%) 6 (0.9%) 
Parainfluenza virus  10 (1.5%)  1 (0.6%) 6 (0.9%)  
Bordetella pertussis    5 (0.7%)      0 (0%) 5 (0.7%) 
Measles virus   4 (0.6%)    0 (0%) 4 (0.6%) 
Chlamydophila pneumoniae   8 (1.2%)    0 (0%)      3 (0.4%) 
Plasmodium falciparum   2 (0.3%) NA 2 (0.3%) 
Adenovirus 40/41 (GE) 10 (1.5%) 6 (3.6%) 1 (0.1%) 
Parechovirus    5 (0.7%)   0 (0%) 1 (0.1%) 
Measles virus    4 (0.6%) 0 (0%) 4 (0.6%) 
Hemophilus influenzae 515 (77%) 130 (78%)     0 (0%)  
Streptococcus pneumoniae 587 (87%) 137 (83%)      0 (0%)   
Adenovirus (GE) non 40/41 45 (6.6%) 53 (32%)      0 (0%)   
Vibrio cholerae   1 (0.6%)     0 (0%)      0 (0%)    
Mycoplasma pneumoniae   2 (0.3%)   1 (0.6%)      0 (0%)    
Astrovirus 10 (1.5%)   39 (23%)      0 (0%)    
Salmonella spp   9 (1.3%)    4 (2.4%)      0 (0%)    
* ETEC expressing either estA and/or 
eltB  
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After application of study specific pre-defined diagnostic criteria using 
clinical characteristics and laboratory results including the above 
described Ct value cut-offs in some pathogens, a cause of fever, was 
assigned to 579/677 (86%) patients of whom 160/579 (28%) had more 
than one final diagnosis. The most common causes of fever were RSV, 
influenza A or B virus, rhinoviruses, enteroviruses, and GAS (Table 2).   
It is difficult to compare our study with previous reports on African 
children considering the substantial differences in methodology and 
inclusion criteria158 159 264-266. Indirect comparisons could be made by 
analysing large studies like the Global Burden of disease that include 
global estimations of mortality and morbidity from different pathogens. 
Yet, more important is probably to compare with aetiology studies like 
PERCH and GEMS that have other inclusion symptoms which indirectly 
cause fever (like diarrhoea and pneumonia).  
Many previous fever aetiology studies are rather exploratory in nature and 
use new point-of-care tests, sensitive molecular analyses or sometimes 
more traditional techniques but might lack a comprehensive paediatric 
approach with a risk of selection bias behind the choice of investigated 
pathogens and their diagnoses.  
A review from Kiemde et al8 published just before paper II shows that 
most fever aetiology studies performed after the introduction of rapid 
diagnostic tests for malaria focused on febrile children under 5, included 
a mixture of inpatients and outpatients and mainly investigated presence 
of bacterial invasive infections but less so viral and parasitic infections. 
Also, of those that include viral infections most analyse only a few agents 
like adenovirus and rotavirus and influenza virus. Kiemde et al further 
illustrated the uniqueness of study 2 by pointing out that no other study 
analyses blood stream, urinary tract, gastrointestinal and respiratory tract 
infections simultaneously. They also emphasized the possible 
disadvantage to only study those with a measured temperature on-site.  
Some recent studies have investigated the aetiology in each patient and 
thereby are easier to compare to study 2. The best example is the fever 
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aetiology study conducted in Tanzania by D’Acremont et al that applied a 
broad microbiology test panel, including PCR and POC diagnostic tests161 
and also retrospectively posed a final study diagnosis on individual level 
based on pre-defined criteria. I 
In contrast to our study 2, they included older children with verified 
fever, both severe and non-severe cases, but did not include a control 
group of asymptomatic children. Their selection of analyses was also 
more complex with a study specific algorithm whereas study 2 used the 
information gathered from the standard of care in Zanzibar, the IMCI 
guidelines and was also less selective on which patients that should be 
tested. Importantly, results from nasopharyngeal PCRs were disregarded 
in the study by d’Acremont et al if there was another systemic (i.e. 
detected by serology or PCR in blood) viral, parasitic or bacterial 
infection detected. Hence, the most important cause of fever in study 2, a 
viral respiratory tract infection was deemed not as important in that 
study. Nevertheless, over 50% of their children had an upper respiratory 
tract infection as cause of fever with the following four top causes: 
Adenovirus, 27%, rhinovirus 21%, influenza A/B 19%, and bocavirus 
11%161. However, study 2 showed that three of those mentioned 
pathogens were regarded as a less likely cause of symptoms and after the 
final interpretation our study considered merely 1% of the final diagnoses 
to be caused by Bocavirus and Adenovirus, respectively. We early on saw 
the need for inclusion of healthy controls, and without the reference of 
asymptomatic subjects, the conclusions on aetiology and final diagnoses 
in study 2 would not have been accurate. 
Yet, d’Acremont’s study team put more efforts into finding invasive 
bacterial infections and systemic viral infections like human herpes virus 
type 6 (HHV-6), cytomegalovirus (CMV) and Epstein-Barr virus (EBV). 
We did not include these pathogens in our study, which might be 
considered a study limitation. HHV-6 is indeed a well-known cause of 
fever in children especially in infants that often are infected during the 
first year of life typically with the clinical syndrome exanthema subitum. 
However, it is often difficult to determine whether HHV-6 PCR 
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positivity is caused by an acute infection, latent infection or asymptomatic 
reactivation without any clinical significance267. Also, it is difficult to 
distinguish between active replication and chromosomal integration into 
the host genome which is estimated to be present in around 1% of the 
population268 269. These difficulties are important to consider since HHV-6 
was identified as the second most common cause of acute febrile illness 
in infants in the study by d’Acremont et al.  
Fourteen percent of the patients in study 2 did not receive a final 
diagnosis. Yet, only 8 patients had no pathogen detected (paper II). The 
corresponding figure in the PERCH13 and d’Acremont study were 1.8% 
and 3%, respectively. This difference could for example be explained by 
that both studies regarded a detection of pneumococci in the 
nasopharynx as a probable cause of disease whereas in study 2, we did 
not since 87% of patients and 83% of controls had pneumococci 
detected in nasopharynx (Table 1). Another reason could be that our 
study interpretation algorithm might have excluded some agents that 
were likely causing the symptoms. One example is norovirus GG2. Ten 
patients had a low Ct value (high pathogen load) for noroviruses but did 
not report three or more stools per day, which was a prerequisite for a 
pathogen found on rectal swabs to qualify as a final diagnosis. But in 
these circumstances, norovirus GG2 could have been a probable cause of 
disease since studies show that at least half of norovirus cases express 
fever and often abdominal pain and vomiting but no diarrhoea270 271.   
Another difference is that study 2 also included patients with only a 
history of fever, who comprised 58%. This might be seen both as a 
limitation -patients included are too well- but also as described above, a 
strength -patients represent those that should be managed according to 
the IMCI fever algorithm since it encompasses history of fever as well-.  
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Arboviral infections and other emerging 
infections  
Indirect comparisons with research on travellers returning from Africa, 
both commercial tourists and so called VFRs (Visiting Friends and 
Relatives) have like study 2 shown that the majority of travel related 
fevers are caused by cosmopolitan infections, i.e. not “tropical diseases”272-274. 
However, in travelling children returning from tropical regions, the three 
most common causes of tropical diseases are not surprisingly, malaria, 
dengue, and enteric fever. Specifically, febrile returnees from sub-Saharan 
Africa had most commonly P. falciparum and rickettsioses whereas dengue 
fever was rare in epidemiological reports from 1999-2011275 276. Previous 
research indicates that rickettsioses are not as common in East Africa as 
in the Southern part, which can explain the fact that that no rickettsial 
infections were found in study 2277. Also, in study 2, no patients had an 
infection with dengue, chikungunya, Rift Valley fever virus or West Nile 
virus, which is in accordance to d’Acremont et al that did not find any 
arboviruses by PCR161. However, when using dried blood spots as in 
study 2, there is a risk for false negative results due to the degradation 
and instability of nucleic acids, in particular for RNA viruses (like 
chikungunya virus, dengue virus, West Nile virus, Rift Valley Fever virus).  
Another limitation was the sampling selection, since study patients were 
only tested for blood pathogens other than malaria if no other cause of 
fever was detected. Also the time period when patients with arbovirus 
infections are viremic (PCR positive in blood) is often short. Still, the 
results are in coherence with other data from both Tanzania and 
Zanzibar conducted around the time of the study where there was no 
research nor official figures that reported acute or previous dengue 
infections in children below 15 years of age278 279.  
However, arboviral infections do exist in Africa and Zanzibar has been 
one of the first places to report dengue epidemics280. Studies indicate that 
dengue has been present in West Africa for at least 30 years281-283. 
Although dengue as a cause of febrile disease in Africa is increasingly 
reaching attention284, previous research are case reports or retrospective, 
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often serology-based285 blood donor data or studies performed in 
travellers that only indirectly identify the presence of dengue in Africa286 
287. Yet, how high the actual disease burden of dengue virus is in Africa 
and Tanzania is still unknown283, and the need for dengue surveillance has 
been highlighted280.  Recently, population based studies across Africa 
have been initiated288 and some with preliminary reports of ongoing 
epidemic transmission289-292. In children, uncomplicated arboviral 
infections are common. Malaria and arboviral infections often have 
overlapping symptomatology and co-infections between malaria and 
dengue have also been reported291. Hence, dengue diagnosis particularly 
in small children is difficult.  
Since the risk of serological cross-reaction is substantial, exposure to 
other flaviviruses than dengue, like zika virus, West Nile fever virus and 
tick-borne encephalitis virus often has to be considered. Attributing 
infectious disease burden in children based on serology results could be 
performed retrospectively19 96 or prospectively293, preferably by detection 
of IgG seroconversion, although detection of IgM on one occasion might 
be sufficient. If a sample is taken shortly -within 1-2 weeks- after debut of 
symptoms, dengue infections may be diagnosed by PCR-based assays or 
NS-1 antigen detection95.  
Chikungunya is an arbovirus that like dengue is transmitted by the Aedes 
mosquito. Chikungunya epidemics in Africa have been described in the 
last decade and are more common than dengue in aetiology studies on 
febrile illness in children264 279.  
The arboviral infections and also some of the other agents analysed on 
dried blood spots in study 2 are often classified as emerging diseases. 
Emerging and re-emerging infections are defined by the United States 
Centre for Disease Control as “infections that have increased recently or 
are threatening to increase in the near future”. Many emerging infections 
increase due to for example over-population, migration and climate 
change294.  
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However, just as important a reason for a reported increase may be the 
fact that many of these pathogens were previously difficult to detect in 
the laboratory. New and more sensitive laboratory techniques combining 
serology with pathogen detection techniques like PCR have been 
developed and might indicate an increasing incidence but in fact those 
pathogens could have been there already before. Also many of these 
pathogens often have no or mild symptoms and a high rate of 
spontaneous cure why the detection of the pathogen might actually be 
made en passant. Examples of this are rickettsioses, leptospirosis, Coxiella 
burnetti (Q-fever) and Borrelia spp 295-299.  
There still needs to be a good collaboration between the clinician and 
laboratory for an accurate diagnosis to be made and to for example avoid 
over-reporting of positive results. Parola, Raoult et al that have 
contributed with new data from Africa on these types of infections. They 
also compared the presence of blood pathogens detected by PCR in 
febrile and afebrile children where malaria followed by S. pneumoniae was 
the dominant pathogens274. However, most of the mentioned emerging 
infections previously detected in adults were not found in children274.  
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Figure 5. Real-time PCR Ct values on baseline (day 0) and follow-up (day 14) for 
selected pathogens. Each line represents one patient. Green lines for cleared infections 
and red lines for new infections on follow-up. Blue lines for agents detected at both 
baseline and follow-up. Ct values<40 were regarded negative.  
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Health outcome, pathogen clearance and new 
respiratory tract infections 
Two children died out of seven of the included children that developed 
severe disease (study 2). Both of the deaths occurred five days after 
enrolment and none of them had a severe bacterial infection or abnormal 
laboratory values on inclusion. In 543/642 (85%) patients, the fever had 
resolved on both of the scheduled follow-ups. An additional 29 children 
had a verified fever relapse on the second follow-up visit (Figure 4 for 
fever resolution). On the 14-day follow-up, 207 patients were randomly 
selected for a pair-wise nasopharyngeal sampling and further real-time 
PCR analysis.  
Ninety-five out of 207 (46%) had one or more new pathogens detected 
that were not seen on day 0. In 157/207 (76%) patients, 199 pathogens 
were detected in the nasopharynx on inclusion. Out of these infections 
81% were not detected on the 14-day follow-up. More than 90% of 
infections with influenza A and B virus, enterovirus, and parainfluenza 
virus were cleared. RSV or rhinovirus constituted 72% of the 36 
pathogens persisting on day 14, but also 44% (51/115) of new infections 
detected on day 14.  
Considering fever resolution, out of the pair-sampled patients, 18% 
(37/207) were febrile on one or both of the follow-up days, of whom 18 
patients had a new infection detected (influenza B (n=5), RSV (n=6), 
rhinovirus (n=5), metapneumovirus (n=1), enterovirus (n=1)). The high 
rates of influenza B and RSV infections on day 0 and among new 
infections on day 14 might reflect on-going epidemics with these viruses 
in Zanzibar at the time of the study. This would fit with the observation 
that influenza virus B often presented as new infections after inclusion, 
since it was the only pathogen significantly associated with presence of a 
measured fever on any follow-up time points (paper IV). 
There was a high pathogen clearance rate for enteroviruses, influenza, 
and RSV (see Figure 5 for visualization) which is in line with previous 
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research that have shown an average shedding duration of less than 2 
weeks300-308. Previous studies of the duration of respiratory infections have 
included fewer patients or have focused on one or a few pathogens, and 
report lower frequencies of pathogens detected309.  
Paper IV simultaneously analysed presence of 22 pathogens using a 
sensitive assay that allows for pathogen quantity estimation. Thereby, it 
was possible to detect reduced microbial load in addition to clearance of 
pathogens when comparing the first with the second sampling. This 
approach in combination with results from the sequencing to 
discriminate rhinovirus and enterovirus were in particular helpful when 
analysing rhinoviruses and comparing data from day 0 and day 14. 
Hereby, we could conclude that the high frequency of rhinovirus both on 
inclusion and follow-up was likely explained by many different rhinovirus 
types circulating simultaneously, resulting in frequent exposure.  
New infections with rhinovirus (48/207; 23%) were also more common 
than persisting infections (12/207; 5.7%). These results are consistent 
with other longitudinal studies reporting that infections with new 
rhinovirus strains are more common than infections persisting >30 
days306 310 311.  Hereby, we were also able to identify that enterovirus, was 
cleared in essentially all cases. 
Some previous aetiology studies disregarded the results from 
nasopharyngeal swab PCRs despite the fact that this is the established site 
of sampling for respiratory tract pathogens that cause a fever. The 
argument has mainly been that pathogens continue to be detected in the 
nasopharynx a long time after the acute illness and are therefore not 
significant. However, this could not be supported by our findings. 
Longitudinal sampling is crucial to understanding the course of 
respiratory tract infections in children.  
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The effects of seasonality 
Study 2 was conducted during and just after the rain season and hereby, 
did not cover all tropical seasons which was a limitation of the study. The 
effect of seasonality on infectious diseases is important and depends on 
environmental factors (like temperature and rainfall), host factors (e.g. 
vector seasonality) and human behaviour (outdoor or indoor activities, 
school or summer holiday)312. In tropical and subtropical climates, these 
changes are in general connected to the annual rain or dry seasons. 
Typically, malaria incidence increases during or just after the rain 
season313. Influenza is present all year round although an increase in 
transmission during or just after the rain periods is pronounced103 104, 
often coinciding with a decrease in temperature.  
Similarly, RSV and general viral detection have also been shown to 
increase during and just after rain falls, in low-income countries in the 
tropical zones306, but specific data from most parts of Africa is lacking314 
315. For some pathogens, the epidemic pattern has to do with the dew 
point temperature (which is correlated to the level of humidity). For 
example enteroviruses that tend to peak during the warmer months, 
although this has mainly been shown in temperate rather than tropical 
climates316.  
Rotavirus transmission has also been described as rain or temperature 
dependent transmission but also the income level of the country where 
the patient resides seems to be important317. Thus, the low rate of 
rotavirus infections in our study might be due to the choice of time 
period for sampling, which also could have influenced the attributable 
fraction for some other pathogens. Also, the fact that we did not have 
any arboviral infections may be a seasonal effect since dengue and 
chikungunya epidemics tend to emerge during the hot318 and dry season279 
rather than the rain season.  
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IMCI classifications versus final diagnosis 
No previous reports have compared IMCI classifications with a final 
diagnosis based on comprehensive laboratory support and pre-defined 
study definitions. The few studies made are difficult to reproduce or 
verify and are neither comprehensive nor clinically useful319 123.   
In our study, the most common IMCI classification was pneumonia, 
(n=387 (57%)), followed by common cold (n=224 (33%)), watery 
diarrhoea (n=164 (24%)), acute ear infection (16 (2%)), dysentery (n=12 
(2%)), chronic ear infection (n=3 (0,4%)) and malaria (n=2 (0,3%)). The 
two patients with malaria also fulfilled the IMCI classification 
pneumonia. More than one IMCI classification was assigned to 25% of 
the patients and there was a substantial overlap between different IMCI 
classifications (Figure 6) what others also have described143.  
This complexity is illustrated by the finding that the symptoms in some 
cases were not typical of the final diagnoses (Figure 7), where for example 
RSV was the most commonly detected final diagnosis in patients with 
diarrhoea. Overlapping gastrointestinal and ARI symptoms have been 
described before in particular for coronaviruses320 and bocavirus321 . This 
brings to light that children have complex illnesses and many fulfil 
multiple IMCI classifications as well as final diagnoses161. This leads to 
the subsequent question, maybe even more important, who needs 
treatment, and who needs antibiotics.   
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Figure 6. Venn diagram displaying overlapping IMCI diagnoses for IMCI 
pneumonia (n=387), IMCI common cold (n=224), IMCI diarrhoea (n=176), 
IMCI ear infection (n=21), and IMCI dysentery (n=12) 
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Infections that require antibiotics  
A majority of the 5.8 million deaths in children is directly caused by 
infections that in many cases probably could be averted with 
antibiotics322. 
In study 2, 74% (500/677) of all patients received antibiotics, whereas the 
antibiotic prescription was lower in study 1 with 58% (1052/1822) to 
children below 5 years of age. All patients were managed according to the 
IMCI, and the health workers were trained in a similar way for both 
studies. Almost every fourth patient (152/677, 22%) had a bacterial 
infection presumed to require antibiotics (Figure 8). The most common 
were throat and/or skin infection with S. pyogenes (GAS) (6%), x-ray 
verified pneumonia (6%), Shigella gastroenteritis (4%), otitis media (4%) 
and urinary tract infection (2%). 
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Figure 8. Proportions of patients with an antibiotic indication by IMCI (IMCIAB) 
and actual antibiotic prescription in patients with and without an infection requiring 
antibiotics (InfRA/no InfRA). Striped areas represent actual antibiotic prescription  
21
24
136
95
18
276
2
105
InfRA, No IMCIAB: 45 (7%) No InfRA, No IMCIAB: 231 (34%)
No InfRA, IMCIAB: 294 (43%) InfRA, IMCIAB: 107 (16%)
Striped areas represents actual antibiotic prescription
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Shigella infections 
Shigellosis is after rotavirus the second leading cause of diarrhoeal 
mortality globally with 60 000 deaths among children below 5 years old6. 
Both of the pathogens were associated with fever in the MAL-ED 
longitudinal birth cohort study on enteropathogen contribution to 
diarrhoeal disease12.  
In study 2, 4% of all patients had Shigella infection as final diagnosis and 
16% of those with diarrhoea or dysentery. Antibiotic treatment is 
recommended for shigellosis infection323. However, the most recent 
Cochrane report compared antibiotics to placebo and concluded that a 
patient that has a mild diarrhoea might not need treatment even if 
Shigella is detected in the stool. In contrast to this, a recent large meta-
analysis showed that the presence of shigellosis is associated with a 
mortality rather than dysentery, 324 . Hence, effective ways to find those 
children that need antibiotics must be investigated186 324.  
Half of our patients with Shigella infections were supposed to receive an 
antibiotic according to the IMCI. Yet, as seen in the Venn diagram in 
Figure 6, only a few would receive the treatment for the indication Shigella 
dysentery but instead most for a pneumonia which is treated with 
Amoxicillin. This is nowadays not sufficient to treat shigellosis, instead 
either a fluoroquinolone or a cephalosporin is recommended. However, 
Shigella strains have emerged that are resistant to these antibiotics, but 
these strains are not so common in Africa as in Asia325. 
Group A streptococci 
Group A streptococci (GAS) are one of the most common and also 
dangerous causes of morbidity and mortality in children.  The highest 
disease burden is in resource limited settings where complications, such 
as septicaemia, acute rheumatic fever, rheumatic heart disease, and acute 
post-streptococcal glomerulonephritis seem to be more frequent. 
Therefore, in these settings, GAS tonsillitis should be treated also for 
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prevention of complications.  In recent years, the usefulness of the 
Centor criteria for clinical diagnosis of GAS infection has been 
questioned, both to rule in as well as rule out the infection326.  
Immunochromatographic tests that detect GAS from throat swabs are 
therefore widely used in conjunction with the Centor criteria, in high-
income settings but not as much in LMICs. Our study had a high rate of 
crude GAS detection of 14% (QuickVue®), and still after the application 
of the pre-defined study criteria that considered reported symptoms and 
concomitantly detected pathogens, the rate was 6%.  In contrast, Kiemde 
et al performed a similar study in Kenya where 10% of included patients 
were treated with antibiotics prior to inclusion (similar to paper II with 
8%). They included febrile patients and healthy controls 1-12 years old 
presenting to a hospital outpatient department. Of these, only 2.3% of 
patients and 0.6% of afebrile subjects were positive for GAS by rapid test 
(Clearview®) and/or culture on throat swabs249.  
Interpretation of GAS rapid diagnostic tests might be a source of both 
false positive and false negative results. Most immunochromatographic 
tests like Strep A tests and mRDTs define positivity regardless of band 
intensity. This could be one reason why D’Acremont et al had no patients 
positive for GAS on throat swabs, but more likely it was due to a narrow 
criteria (history of sore throat) for rapid test sampling since it is difficult 
to assess throat pain in a child <5 years old161.   
Urinary tract infections 
Urinary tract infections (UTI) and pyelonephritis are one of the most 
common bacterial causes of fever in children, especially in infants with 
the long term risk of renal damage. Most studies find rather unspecific 
symptomatology in patients with UTI327. UTI prevalence is estimated to 
be more than 10% in admitted febrile children <5 years of age in SSA327-
329. Our study showed that 2% of febrile young children had a UTI, but 
the crude prevalence in this population is probably higher if children 
without fever and those few with concomitant UTI and diarrhoea would 
be sampled. In addition, the study definition of a UTI was; a significant 
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growth in urine of ≥107 colony forming units/L as well as a positive 
leukocyte esterase or nitrite in urine. Indeed, other studies disregarded the 
latter of the mentioned criteria and included more symptoms to find the 
UTIs although this might lead to a risk of interpreting asymptomatic 
bacteriuria that does not need a treatment as a UTI  that require 
antibiotics330.  
Many children in low resource settings do not have access to prescription 
of the right antibiotic in due time when they need it.  Indeed, paper II 
showed that not only over- but also under-prescription or -treatment of 
antibiotics is a fact in low- and middle-income countries like Zanzibar331 
332.  
To serve as an example, a Nadjm et al showed that one third of children 
admitted due to febrile illness that needed antibiotics still did not receive 
it when assessed and managed according to the WHO guideline 
“Management of the child with a serious infection or severe malnutrition: guidelines for 
care at the first-referral level in developing countries”. A high rate of antibiotic 
resistance was also seen. Also, half of the patients with an SBI had a non-
typhoidal salmonellosis which probably would not be cured by the 
prescribed antibiotic treatment anyway333 due to antibiotic resistance of 
NTS and/or that most first or even second line antibiotics do not target 
NTS.   
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IMCI antibiotic treatment versus antibiotic 
requirement 
Among the 525 patients without infections requiring antibiotics, 294 
(56%) had an IMCI indication for antibiotics, a majority of them due to 
IMCI pneumonia (paper II). The two patients with malaria in study 2 
received antibiotics because of IMCI pneumonia (Figure 6), which was 
the most common cause of “overtreatment” in study 2. In study 1, the 
antibiotic prescription rate was significantly higher in older children and 
adults in RDT negative (1145/1968 (58%)) than RDT positive patients 
(14/85 (16%)).  However, in children under five it was similar in RDT 
positive and RDT negative patients of whom most received an antibiotic 
due to IMCI pneumonia.  
These results are in line with a study from Zanzibar by Msellem et al that 
reported an antibiotic prescription of 69% in children under 520. 
Moreover, they showed significantly higher antibiotic prescription in 
patients tested with mRDT and in those with clinical presumptive 
diagnosis20 334. The latter study was performed in 2005 when every third 
patient had malaria but a recent meta-analysis of over 500 000 
consultations in Africa and Asia confirms this effect of mRDTs on 
antibiotic prescription. Antibiotic prescription was consistently and 
significantly higher through all studies in sites that used an mRDT. It is 
important not to draw conclusions too quickly since overprescription was 
probably there already before, but might have been brought to light by 
these recent studies.  
Yet, a multi-country evaluation that analysed demographic health survey 
data reported clear differences between countries after the introduction 
of mRDTs. Some countries had a significantly higher and some lower 
antibiotic and/or antimalarial prescription rate in patients that were tested 
with an mRDT 335. This shows the complexity of introduction of a new 
diagnostic test and the need for supervision and surveillance.   
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Like study 2, other comprehensive studies have also shown that most 
children have a viral infection and only a minority of the children with 
fever need antimicrobial treatment161 162 249 264. Health workers need 
support in further fever management of negative mRDT patients 
including guidance on antibiotic and antimalarial prescription336 337.  
One successful example is the e-health algorithm ALMANACH, which 
was developed based on the results from d’Acremont et al161 and is a 
further development of an electronic version of the IMCI guideline. The 
most important revision is the change in the cut-off that define a fast 
breathing from 40 breaths/minute in IMCI (2014) to 50 breaths /minute 
in ALMANACH and the addition of a urine dipstick and a typhoid test 
to selected patients338. The ALMANACH approach was evaluated in a 
non-inferiority trial in Tanzania and there was no difference in health 
outcome but antibiotic prescription decreased with 80%339.  
Ameyaw et al combined the introduction of a malaria RDT with a test 
and treat package in the outpatient department of a hospital in Ghana. 
Patients that had a normal clinical examination - no positive findings on 
examination of the lungs, ear, throat and joints - and a negative malaria 
test and urine dipstick for leukocytes and nitrites were regarded to have a 
“possible viral infection”340. Moreover, for those that were diagnosed 
with a bacterial infection, the choice of antibiotic was amoxicillin-
clavulanic acid to cover for urinary tract infections. They showed that 
patients of the test-treat arm were prescribed less antimalarials and 
antibiotics and still had a significantly better outcome (less 
hospitalizations) than routine care.  
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Is pneumonia the new malaria?  
Bacterial infections are the most common cause of mortality in children 
globally.  Hence, many patients are in need of antibiotics, but 
overtreatment is common. As already mentioned, after the introduction 
of malaria RDTs there is a worry that patients with a negative malaria test 
would automatically receive antibiotics instead341. This is further 
demonstrated by the case of pneumonia. Paper II showed that 57% of 
patients had an IMCI pneumonia of whom 42/342 (12%) had a 
radiological pneumonia. This result is in line with previous studies that 
have a chest X-ray verification in 10-20% of patients with clinically 
suspected pneumonia144 342-344 of which most but not all used the 
systematic WHO criteria used in paper II148.  
But should all antibiotic courses given to children that did not have a 
positive chest X-ray really be classified as overtreatment? Critics to using 
CXR as gold standard claim that the presence of an infiltrate is 
independent of both final outcome and aetiology140. In addition, 
qualitative radiology services are rare in resource-limited settings, and the 
main clinical reason against is that there is some delay until a pneumonia 
is visible on the radiograph345. Nevertheless, in the PERCH study there 
was an increased risk of death within a 30-day follow-up period for 
children with an abnormal CXR346. Also, the disease reductions after the 
introduction of pneumococcal vaccines were seen for invasive 
pneumococcal disease and radiological pneumonia but not for IMCI 
pneumonia347.  
Patients with IMCI pneumonia might have other causes of disease like 
bacteraemia or otitis media that are averted with the antibiotic treatment 
intended for the pneumonia. This is illustrated by a study from Tanzania 
in 2005. Before the introduction of pneumococcal vaccine almost 7% of 
patients with mild pneumonia had sepsis, 38% of which was due to 
invasive pneumococcal disease348.  
What happens with febrile patients that do not receive any antibiotic or 
antimalarial treatment? In a study from Zambia, most RDT negative 
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children recovered on antipyretics alone349. In study 2, the prevalence of 
severe bacterial infections (SBI) was 50/677 (7,4%).  Three of these 
patients did not receive antibiotics but recovered anyway (paper II). A 
proportion of infections that according to guidelines require antibiotics 
do heal without treatment, for example otitis media, pneumonia350, GAS 
tonsillitis and Shigella infections.  
So out of all patients with IMCI pneumonia, who benefits from antibiotic 
treatment? In the last decade the duration of antibiotic treatment for 
IMCI pneumonia (2014 version) has been reduced from 5 days to 
optional 3 days based on studies in Asia351. Furthermore, studies from 
Papua Guinea and Pakistan reported no differences in outcome in non-
severe IMCI/WHO pneumonias with or without first-line antibiotic 
treatment352 353. Also, a 2016 Cochrane report concluded that there was 
not sufficient evidence for the benefit of antibiotics to neither otitis nor 
fast breathing pneumonia according to IMCI350 and that there was a need 
for further evidence.  
Thus, recently a randomized control study from Malawi again evaluated 
the 3-day amoxicillin regimen versus placebo in children 2-59 months 
with non-severe IMCI pneumonia. There were no deaths, but the study 
was prematurely interrupted due to a higher rate of treatment failures in 
the placebo group. The number-needed-to-treat to prevent one failure 
was 33 patients.  
Further analysis of the clinical data in the Malawi study did not find any 
prognostic risk score to aid antibiotic decision-making354. A retrospective 
sub-group analysis was conducted of community recruited children in 
Malawi who did not receive antibiotic treatment (cotrimoxazole) for 
IMCI pneumonia. Patients without treatment had worse clinical 
outcomes than patients that were treated with antibiotics.  They were also 
more likely to be sicker on inclusion. Again the need for clinical decision 
support is vital, including which treatment to recommend for pneumonia. 
In particular in a high endemic HIV setting with a probable higher 
proportion of fevers that are caused by gram negative infections, 
cotrimoxazole might be better than amoxicillin 355.  
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Inflammatory biomarkers to guide management 
Most of the management guidelines for preschool children used on the 
first level of health care in resource limited settings, combine history, 
symptoms and vital signs to distinguish a healthy from a sick child 21. 
However, using only clinical examination has an unsatisfactory level of 
sensitivity and specificity for detection of severe disease.  
Could inflammatory biomarkers like C-reactive Protein (CRP) or 
procalcitonin (PCT) be a tool both to rule in or rule out infection? CRP is 
an acute-phase reactant used in primary health care world-wide to 
distinguish viral from bacterial disease and has been shown to be helpful  
in the identification of which children that have serious bacterial 
infections in Europe218 and Africa345 346. CRP has not been evaluated as a 
complement to IMCI in neither pneumonia diagnosis nor overall 
antibiotic requirement, mostly because comprehensive aetiology studies 
on all-cause febrile illness have not been performed.  
In study 2, CRP was the only independent variable significantly associated 
with radiological pneumonia in a univariate and multiple logistic 
regression (p<0.001), but a cut-off for identification of CXR verified 
pneumonia that had an acceptable level of sensitivity could not be found. 
For example, 36% of patients with CXR pneumonia had a CRP <20 
mg/dL. The PERCH study showed in line with study 2 that CRP was 
significantly higher in those patients with a confirmed bacterial 
pneumonia than with an RSV pneumonia356. ROC-analysis showed that a 
cut-off of 37.1 mg/L had the best discrimination. Still, the sensitivity of 
this cut-off was 77% and it might not be acceptable not to treat 23% of 
the pneumonias that are likely to need treatment.  
Keitel et al further developed the E-POCT guideline based on the above 
mentioned ALMANACH guideline and added both CRP and PCT to 
selected patients. A non-inferiority trial showed that the E-POCT caused 
a reduction in antibiotic prescription from 95% to 11.5% as well as a 
significant reduction in clinical failures357. Similar results have emerged 
from other sites in Asia358 359. 
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In the last decade, there has been an increasing interest in various 
biomarkers for use in the clinical decision of antibiotic treatment. CRP 
has stood out as the inflammatory marker candidate that has the potential 
to reduce antibiotic prescription with cut-offs for treatment above 10-40 
mg/L356 359-363 ,. There are also available low cost POC tests364. There 
might be a possible development of stepwise decision models using so 
called classification and regression tree analysis (CART)102 365. The 
million-dollar question however, is to find the patient that needs 
antibiotics in routine clinical care. This should be given higher priority 
than finding those that do not need it. So in the meantime, there can be no 
other choice for the frontline health care workers in low resource settings 
but to choose the antibiotic rather than no treatment.    
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CONCLUSIONS 
• The sensitivity of the malaria rapid diagnostic tests in comparison 
with both malaria microscopy as well as malaria PCR was 
relatively low. Thus, in addition to quality control and supervision 
more sensitive tools than histidine-rich protein 2 (HRP-2) based 
mRDTs might be called for in a malaria pre-elimination setting 
like Zanzibar.  
• The adherence of health workers to the mRDT was excellent also 
when used as a part of the IMCI. This shows that the mRDT can 
reliably be integrated into the IMCI for malaria diagnosis.  
• The vast majority of children with uncomplicated fevers 
presenting to primary health care have a viral infection as a cause 
of fever. One in four has an infection that requires antibiotics.  
• It is common that fever patients and healthy controls have similar 
detection rates of respiratory tract pathogens and diarrhoeal 
pathogens.  
• The interpretation of threshold cycle (Ct) values as a proxy for 
pathogen load in faecal samples may, for some pathogens, be 
crucial when attributing cause of symptoms.  
• Children with acute uncomplicated febrile illness in Zanzibar had 
a generally favourable outcome and rapidly cleared respiratory 
tract infections, but they frequently acquired new infections 
within two weeks.  
• The current fever management guideline, IMCI, does not seem to 
adequately identify neither children that need antibiotics, nor 
those that do not. 
• C-reactive Protein might be a useful biomarker for future 
intervention studies in particular to rule out that a patient has an 
antibiotic requiring infection. 
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PERSONAL REFLECTIONS AND FUTURE 
PERSPECTIVES  
Twenty years ago I came as a tourist by boat from mainland Tanzania to 
Zanzibar. The reaction that I got before going there from people living in 
Dar Es Salaam was, “Oh Zanzibar, it is beautiful but beware of all the 
malaria”. 
 Since then, malaria community prevalence has decreased by 96%19 and 
tourists are now being advised not to take malaria prophylaxis due to the 
low malaria risk. Health care workers are aware of the fact that malaria is 
not as common anymore366 and in 2009-2010, during the planning and 
conduct of the first study in this thesis we saw that the health care 
workers trusted the mRDTs and managed patients according to it336. Yet, 
the question that often came up was; “Ok, if it is not malaria, then what is 
it?”. This thesis also aimed at answering that question.  
By providing extended explorative information on aetiology and 
comparing it with clinical signs and symptoms, this project added 
knowledge for improved management of the feverish child through 
accurate diagnosis and ultimately better treatment.  
The main results that emerged were that the rapid diagnostic tests for 
malaria used in Zanzibar in 2010 were below standards and that non-
severely ill febrile children below the age of five in Zanzibar had viral 
infections. So called tropical illnesses were rare. Comparison with healthy 
controls provided invaluable information on aetiology. Both over- and 
underprescription of antibiotics was common but no clinical sign or 
laboratory test could single out antibiotic requirement in a child. By 
comparing the present results with recent studies from other research 
groups this thesis also outlined typical examples of common risks of bias 
and pitfalls that could be encountered in clinical research on infectious 
disease aetiologies.  
 88 
Improved diagnosis of febrile illnesses in children in areas that lack access 
to health care with qualified staff and modern equipment must be a top 
priority. Zanzibar could serve as a model for the rest of Africa making 
this study a pilot project not only for East Africa but the whole SSA, 
particularly for low endemic malaria regions. With the results, we aimed 
to shed light on febrile disease in low-resource settings and provide 
hands-on paediatric health information for local, regional and global 
decision-makers.  
Following the recent decades of large success in malaria control, there are 
worrying indications that the reduction has halted in the region367 in the 
last couple of years, as indeed foreseen by many researchers and policy 
makers19.  
The WHO Malaria report issued in 201826 a warning that on a global 
level, no significant progress in reducing malaria cases was made in the 
recent couple of years. Instead malaria even increased in the ten countries 
with the highest malaria burden, with an estimated 3.5 million more cases 
of malaria in 2017 in comparison with 2016368. The ambitious target of 
the Sustainable Development Goals (SDG) initiative to reduce malaria 
incidence and prevalence with 90% from 2015 to 2030 is threatened. 
Only 50% of people living in malaria endemic countries have access to 
vector control and only 20% of pregnant women receive intermittent 
presumptive treatment of malaria. This is alarming and should be the 
focus of policy maker attention. But non-malarial fevers must still not be 
forgotten since mortality in this group is often higher.  
What implications might the results of the study have on routine clinical 
management, on Research and Development or on advocacy issues in 
Zanzibar and sub-Saharan Africa? What is the way forward? Firstly, for 
future studies to be useful, a less exploratory approach should be sought 
by using well defined and reproducible qualitative or quantitative 
methods that aimed to improve important clinical outcomes, like reduced 
mortality or hospitalisation and improved epidemiology and outbreak 
surveillance, so called “Translational research”.  
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Secondly, with this in mind, is the introduction of additional POC tests to 
the already widely implemented malaria RDTs the future of paediatric 
fever case management in Africa? Or should management instead include 
key equity predictors in the clinical assessment to receiving the right 
treatment like level of maternal education, country/place of residence, 
and socio-economic status369?  
It is already now evident in Africa, that a high percentage of children do 
not receive testing or treatment for malaria or pneumonia370. Is adding on 
to the number of clinical assessments and procedures that the health care 
worker has to perform on the patients going to save lives or alleviate 
suffering? If one has to prioritize, maybe a focus on decreasing the 
amount of time it takes to get to proper health care or investing in 
emergency triage and treatment in the peripheral health facilities would 
have more impact on morbidity and mortality.  
POC tests started to be of interest after the relative successful 
introduction of malaria rapid diagnostic tests. A POC test should be easy 
to interpret, and preferably provide a qualitative test result, i.e. 
positive/negative. It should directly give information on treatment or 
management, take less than 15 minutes, be cheap or at least have the 
potential of being low cost, preferably not having a need for cold chain or 
electricity.  The WHO have set up the following mnemonic for the ideal 
POC tests: ASSURED (Affordable, Sensitive, Specific, User friendly, 
Rapid (treatment at first visit) and Robust (no cold chain needed), 
Equipment free and Delivered to those who need it)371.  
As much as I believe in the importance of providing up-dated regional 
data on infectious diseases in poor countries, I see a possible danger with 
the implementation of new and appealing techniques like metagenomics 
or a variety of POC tests in that it could satisfy the interests of academics, 
politicians, military researchers or philanthropists in microbes or global 
vital statistics data but it might not be important for survival of the 
poorest. Just because something is common does not mean that there is a 
need for a POC test in daily routine care. For example, a POC test for 
dengue case management in Asia probably does not save lives or improve 
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clinical management to the extent as an RDT for malaria in Africa does. 
On the other hand, it may be very useful for surveillance and case 
detection371. However, a POC test for the decision on when not to treat 
with antibiotics might provide a safer option than placebo for the 
treatment of clinical pneumonias in the peripheral health facilities. 
Also, with the higher set SDGs that have replaced the Millennium 
Development Goals (MDGs) which should reach every child on the 
planet, a POC test may be advocated for.  In my view, whatever the 
intervention, the most important thing is to remember, that the time is 
over when we can believe that a few diagnostic tests, guidelines, vaccines 
or antibiotics save all.  
The future to improve the outcome of children with fever in Africa is to 
apply equity standards, and focus more on the poorest and youngest. It is 
time to get rid of poor clinical management of poor children living in 
poor areas. New promising techniques be it telemedicine372, electronic 
management tools373, metabolomics374, or metagenomics375 still need 
accurate clinical management, laboratory standards of procedures and 
data provision on ground.  There is still the need of a health worker or 
laboratory assistant to correctly prepare a blood slide, conduct an X-ray 
or a point-of-care ultrasound. Thus, investing in human resources is 
probably even more important under those circumstances. Another test 
needs just as much human involvement and quality assurance, only in 
another way. And remember, poverty is still the main killer in children 
and not pathogens.  
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